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ABSTRACT 
 
JOHN E. BYRD:  Impact of Medication Stressors on Emotional Health of Informal 
Caregivers of Demented Patients 
(Under the direction of Betsy Sleath, PhD) 
 
 
Purpose:  To better understand the medication-related concerns of dementia caregivers, their 
impact on caregiver emotional health and to identify potential areas for interventions that 
might assist them with medication management and reduce their overall stress and burden.   
 
Scope:  Since demented patients lose their cognitive ability to manage their own medications 
early in the disease process, informal caregivers are involved with this sometimes complex 
process for an extended period of time which has the potential to cause a great deal of 
burden, anxiety and frustration.   
 
Methods:   This research study was conducted using a sample of 139 caregivers of persons 
with memory problems recruited from caregiver support groups, clinic settings and an online 
listserv.   
 
Results:  Caregivers who reported lower levels of social support and had more difficulty 
handling the medication effects reported higher depression scores.  Less than half of the 
caregivers surveyed believed that their pharmacist was proactive in communicating drug 
information or that there was a private place within the pharmacy to do this. 
 iii
Conclusions:  The findings suggest that medication-related stressors are associated with 
poorer emotional health outcomes in caregivers.  The descriptive analysis of caregiver’s 
attitudes about pharmacists and pharmacy services also suggests that there are things that can 
be done to assist caregivers to improve the relationship and communication with their 
pharmacist.   
 
Key Words:  dementia; caregivers; medications; depression 
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CHAPTER ONE 
INTRODUCTION 
 
Memory problems often referred to as Alzheimer’s disease (AD) and dementia is a 
growing public health concern and caregivers are an integral part of the care process.  There 
are currently over 4.5 million adults who live with dementia in the United States and are 
being cared for by informal caregivers (e.g., family members, friends) (Alzheimer’s 
Association, 2006).  Informal caregivers play a prominent role in the ongoing care of the 
demented patient.  As the cognitive ability and functional status of the demented patient 
declines over time, the responsibility of obtaining medical care and maintaining the ongoing 
health status of the patient falls on the primary caregiver(s).  On a broad level, this 
responsibility includes preventative care (e.g., screenings), management of behavioral 
problems, and recognizing the need for primary, secondary or tertiary care for management 
and exacerbations of chronic illnesses.  On a daily basis, this means that the caregiver must 
schedule medical appointments and administer medications and other types of treatments and 
care in order to maintain the demented patient’s physical and mental health. 
As the responsibilities of the dementia caregiver increase over time with the growing 
complexity of care, there is the potential for the caregiver to experience increased emotional, 
physical and financial stress and burden.  Caregiver health has been an area of focus for 
research over the past two decades.  Many studies have examined the impact of the 
caregiving process on both the physical and mental health of the caregiver.  Research efforts 
have been focused on understanding the cause of stress and burden and developing 
interventions to alleviate it. 
Since demented patients lose their cognitive ability to manage their own medications 
early in the disease process, informal caregivers are involved with this sometimes complex 
process for an extended period of time which has the potential to cause a great deal of 
burden, anxiety and frustration.  The overall objectives of this study were to better 
understand the medication-related concerns of dementia caregivers and to identify potential 
areas for interventions that might assist them with medication management.  The caregiving 
process is important and ultimately the health of both the care recipient and the caregiver are 
affected.   
This research study was conducted using a sample of caregivers of persons with 
memory problems recruited from caregiver support groups, clinic settings and an online 
listserv.  Caregivers were administered a self-report questionnaire designed to collect the 
following information about the caregiving process:  caregiver and care-recipient contextual 
information (e.g, demographics, health status), medication-related stressors (e.g, issues with 
administering medications, managing effects and side effects of medications, obtaining 
prescription medications), social support (e.g., pharmacists), and emotional health outcomes. 
Studies have already shown that the overall caregiving process causes depressive 
symptomatology and compromised emotional health in caregivers.  This study further 
contributes to the research of:  (1) the overall depression associated with caring for AD 
patients, (2) specific medication-related stressors experienced by caregivers and their impact 
on the caregiver’s emotional health, and (3) survey instrument development for medication-
related issues experienced by caregivers.  The study will also identify potential opportunities 
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for pharmacy interventions for AD patients and their caregivers.  This study is one of the first 
to use an instrument that asks questions related specifically to the medication management 
responsibilities of the caregiving process in conjunction with a caregiver time activity survey.  
This study adds to the previous literature because it examines whether these medication-
related stressors influence caregiver emotional health.  Identifying the medication stressors 
that impact caregiver-reported health outcomes allows us to make specific recommendations 
for pharmacist-based interventions.  Overall, this study contributes to the growing body of 
research and literature that explores emotional health of caregivers and continues to help us 
understand how we can work to alleviate their burden. 
This dissertation is organized by beginning with a review of the current literature that 
will demonstrate the prevalence of dementia in the United States, the role of caregivers, the 
negative impact of caregiving on the caregivers emotional health status and the role of 
medication management in the process of caregiving (Chapter 2).  The last part of this 
chapter will outline the conceptual framework that shapes the research.  This will be 
followed by the current study’s research hypothesis and specific aims (Chapter 3).  In 
Chapter 4, the rationale and process for developing a self-report study questionnaire for 
primary data collection will be detailed.  The process of developing the questionnaire was 
closely tied to the conceptual framework.  The research methods used to analyze study 
hypotheses and specific aims are in Chapter 5.   This chapter describes the study 
questionnaire and details the work that was done to access caregivers of persons with 
memory problems.  This is followed by the study results in Chapter 6.  Finally, Chapter 7 
summarizes the major findings from this research and discusses implications for caregivers, 
health care professionals (including pharmacists), and health services researchers. 
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CHAPTER TWO 
REVIEW OF LITERATURE 
 
2.1. Overview of Chapter 
 
This chapter outlines key literature findings related to dementia, caregivers, caregiver 
emotional health and medication management.  The first section provides an overview of 
dementia which will include its prevalence, the most common diagnostic forms, its 
anticipated growth in the United States and the impact of the cost of the disease on society.  
Next, I will discuss the role of caregivers in the provision of care for the person with memory 
problems and demonstrate how the burden of this responsibility can negatively impact the 
caregiver’s emotional health.  Third, the available literature on medication management by 
caregivers is presented and the limited information that is available on this topic related 
specifically to caregivers of persons with memory problems is covered.  Then, social support 
and social networks for caregivers is described with a discussion of how pharmacists might 
play a role in the support system.  Finally, the conceptual model used for this research is 
detailed to demonstrate how a modified version of the Pearlin Stress Process Model of 
Caregiving (Pearlin et al 1990) was developed. 
2.2. Dementia 
 
Dementia is primarily an age-related and irreversible brain disorder that begins with 
memory loss, which worsens over time and eventually results in functional losses and 
behavior changes (Cummings JL 2002; Henderson and Jorm, 2000).  There is a progressive 
decline in cognitive ability (e.g, critical thinking, decision-making, speech) and an eventual 
loss of motor and physical functions (American Psychiatric Association, 1997).  “The 
essential features of dementia are multiple cognitive deficits that include memory impairment 
and at least one of the following: aphasia, apraxia, agnosia, or a disturbance in executive 
functioning” (American Psychiatric Association, 1997).  The level of cognitive decline and 
onset of symptoms varies between types of dementia and within patient populations. 
Alzheimer’s disease (AD) is the most common form of dementia, accounting for 50 to 
75% of all cases, and primarily affects the aging population with prevalence dramatically 
increasing with age (Alzheimer’s Association, 2006).  Another 20 to 30% of dementia cases 
are typically diagnosed as vascular, or multi-infarct, dementia (Cummings and Beson, 1992).  
Differential diagnosis between AD and vascular dementia is clinical and based on diagnostic 
criteria.  A small percentage (less than 10% of all cases) of dementia diagnoses are related to 
other less common causes such as Parkinsons disease, human immunodeficiency virus 
(HIV), Lewy body disease, Pick disease and frontal lobe disorders (Henderson and Jorm, 
2000).  For the purposes of this research study, dementia caregivers were those who care for 
patients who suffer from any form of dementia as there was no method of verifying the cause 
of the memory problem.   
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Memory problems are a growing public health concern in the United States because of 
their impact on individuals, families and the health care system.  There are currently 4.5 
million elderly persons in the United States living with AD alone and this number is expected 
to increase with the growth in the elderly population (Alzheimer’s Association 2006).  If the 
current population trends continue and no preventative treatment is developed, the number of 
patients will increase to over 13 million by 2050 (Herbert et al, 2003).  Prevalence depends 
on the type of the dementia diagnosis; however, in all cases, prevalence increases 
dramatically with age.  Dementia affects between 5 to 8% of the population between the ages 
of 65 and 74, 15 to 20% of the population between the ages of 75 and 84 and it may be as 
high as 50% in elderly persons over the age of 85 (Evans et al, 1989). 
With the growing number of people suffering from dementia and the rising costs of 
caring for these individuals, there is also a large economic cost associated with this 
population.  It is estimated that the annual costs (both direct and indirect) of caring for these 
patients maybe be as high as $100 billion (Ernst and Hay, 1994; Ernst et al, 1997).  In 2001, 
Moore et al reported that the average annual cost of dementia caregiving was $18,385 with 
one-third of that cost attributed to caregiver time and the other two-thirds due to lost wages.  
In a 2002 report to the Alzheimer’s Association on the cost impact of AD, Koppel predicted 
that the disease would cost American businesses $61 billion that year which was doubled 
from the amount in 1998.  Over half of these costs, a projected $36.5 billion, were attributed 
to caregiver absenteeism from work, decrease in caregiver productivity while at work and 
replacement costs.  The cost impact of caregivers on businesses far exceeds the $24.6 billion 
paid for the actual health care expenditures of the person with AD (Koppel, 2002).  These 
figures are expected to continue increasing as more people are diagnosed with this disorder. 
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2.3. Informal Caregivers of Dementia Patients 
 
While the progression of dementia is highly variable between patients with some 
experiencing rapid decline in functional status and others who plateau for extended periods 
of time, the disease is highly dependent on caregivers providing support at some time for 
help with patient Activities of Daily Living (ADLs) and Instrumental Activities of Daily 
Living (IADLs) (Clipp and Moore 1995).  Eventually, these caregivers are involved in every 
aspect of daily life for the demented person as these patients require more hours of support 
and greater levels of care than physically disabled elders without cognitive impairment.  The 
primary caregivers and family members are often involved in managing the behavioral 
problems, other chronic health conditions, preventative care and medications of the demented 
patient.  While some of these patients live in institutions (e.g., assisted living facilities, 
nursing homes), more than half of them live at home where 75% of their care is provided by 
an informal caregiver who is a spouse, family member, or friend (Alzheimer’s Association 
2002).  These caregivers are usually spouses or children of the demented patient and are also 
living with their own compromised health and other life stressors (Sleath et al 2005).  The 
majority of informal caregivers are women (Ferrini and Ferrini, 2000). 
 7
2.4. Caregiver Emotional Health 
 
As the memory and behavior of the demented patient becomes more impaired, there is a 
greater dependence on the caregiver that leads to increased emotional, physical and financial 
stress and burden.  While much of the funding for AD research is focused on causes, 
diagnosis and treatment, more emphasis has been placed on the personal and emotional 
impact of the disease on families and caregivers during the past decade (U.S. Department of 
Health and Human Services, 2004).  The study of caregiver health-related quality of life is 
important in understanding the impact of caregiving on caregivers’ emotional well-being.   
Providing extensive daily care for persons who suffer from AD or other dementing 
disorders is stressful and many studies have documented the effect of caregiving on both the 
physical and emotional well-being of informal caregivers (Zarit et al 1996).  Caregivers have 
been shown in research to have poorer physical and mental health outcomes than non-
caregivers (Schulz and Beach, 1999; Wilcox and King, 1999).  There have been more studies 
that have documented the psychological impacts of caregiving.  Zarit et al (1996) found, in a 
study of caregivers assisting a relative with AD or other dementia, that 47% demonstrated 
clinically-significant levels of depression.  The prevalence of depression in caregivers is 
higher than in those who do not have caregiving responsibilities with 30 to 55% of caregivers 
reporting depressive symptomatology (Schulz and Martire, 2004).  A more recent study using 
the National Longitudinal Caregiver Sample by Sleath et al (2005) has shown that nearly 
30% of informal caregivers of demented relatives demonstrate depressive symptoms.  
Depression is one of the most common consequences of caregiving and can lead to poor 
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quality of life, functional decline and mortality (Donaldson et al, 1997, Haley WE et al, 
1995; Perel VD, 1998; Schulz and Beach, 1999). 
This area of research has also been very important to the National Institutes of Health 
(NIH), as well, over the past decade.  Resources for Enhancing Alzheimer’s Caregiving 
Health (REACH) was funded by the National Institute on Aging (NIA) and the National 
Institute of Nursing Research (NINR) and began in 1995.  The goal of this research, 
conducted at six university sites across the United States was to develop interventions for 
family caregivers.  This project was extended to REACH II in 2001 and was focused on 
interventions that would reduce depression and burden of the caregiver 
(www.edc.gsph.pitt.edu/reach).  Several publications of findings from REACH demonstrate 
effective intervention strategies that can be used to improve the emotional health outcomes of 
caregivers of persons with memory problems (Schulz et al, 2003).  These interventions range 
from education, behavioral skills training, use of information technology and environmental 
skill-building (Burgio et al, 2003; Burns et al, 2003, Eisdorfer et al, 2003; Gitlin et al, 2003).  
These studies show that ongoing efforts that focus on improving caregiver emotional health 
can be effective.  The current research study contributes to the literature by further reporting 
the overall depression associated with the caregiving process and identifying possible areas 
for interventions in the medication management process.  
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2.5. Medication Management by Informal Caregivers 
 
One of the first cognitive functions lost by the persons with memory problems is their 
ability to manage their own medication regimens.  Since they live, on average, eight years 
after the onset of symptoms, managing the medications becomes a stressful event for the 
caregiver that can extend over many years (Alzheimer’s Association 2002).  Caregiver 
anxiety and frustration associated with medication management can be attributed to its 
complexity.  The caregiver’s medication management responsibilities extends beyond simple 
administration of the medication and includes managing adverse events, evaluating the 
effectiveness of the medication regimen, obtaining the medications (which includes 
physically obtaining from the pharmacy and financially being able to afford them), and 
gathering information about the medications to ensure that the patient receives optimal 
therapy and avoids complications. 
There have been few studies that have identified specific medication-related stressors 
and their subsequent impact on the caregiver’s emotional well-being.  Therefore, it is 
important to continue doing research that will help us to understand the types and extent of 
the medication-related stressors, the social support that exists related to medication 
management and, ultimately, their impact on the emotional health and stress of the caregiver.  
Francis et al (2002) reported the roles of informal caregivers in the management of 
medication from their British study of 684 caregivers recruited from 26 pharmacies.  The 
goal of this study was to document and quantify the frequency and range of medication-
related tasks assumed by an informal caregiver.  They identified ten medication-related tasks 
and found that they were positively associated with caregiver strain and negatively associated 
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with social functioning and mental status.  All of the medication-related tasks involved 
ordering and obtaining prescriptions, assisting with medication administration, making 
clinical judgments about changing doses and noticing, and managing side effects of the 
medications.  Caregiver burden was measured using the Carer Strain Index (CSI).  The CSI 
was positively associated with the number of medication-related activities undertaken by the 
caregiver after controlling for caregiver age and socioeconomic status and was an important 
part of the caregiver process.  This study did not identify specific intervention opportunities 
for pharmacists; however, qualitative comments from the survey indicated that pharmacists 
should be more involved in the medication-management process to help caregivers be more 
effective in their role. 
Ranelli et al (1994) reported medication-related stressors in a descriptive analysis of 
responses from thirty-one caregivers in Northern Florida.  These caregivers identified 
adverse effects, lack of improvement while on medications, inability of patient to manage 
medications, compliance problems, and lack of professional advice as the primary stressors.  
Ranelli et al also found that the caregivers primarily used the same pharmacy and would like 
more help from the pharmacist in managing medications.  Caregivers said they wanted the 
pharmacists to provide more individualized care, to make recommendations for managing 
adverse effects, to provide information about home medical equipment and non-prescription 
purchases that would improve the quality of care for the patient and to explain how the drug 
therapy works and methods for managing adverse events.  This study demonstrated that 
medication-related stressors exist among caregivers and that there are potential interventions 
and support from pharmacists that would relieve this burden.  However, the Ranelli et al 
study (1994) was limited by its small sample size. 
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Neither the Francis et al (2002) nor Ranelli et al (1994) study examined the impact of 
medication related-stressors on the emotional well-being of dementia caregivers.  These 
studies were conducted in caregivers of elderly patients.  Dementia caregivers are more 
involved in the medication management for the patient than caregivers of other elderly 
persons.  Thus, there is a need to better understand the role of medication management 
specifically within dementia caregivers.  In documented caregiver research, surveys of 
dementia caregivers, including the National Longitudinal Caregiver Sample conducted in 
caregivers of veterans with AD and vascular dementia, have only measured the medication-
related activities and other caregiving tasks of the caregiver in terms of time spent on the 
activity.  In 1995, Clipp and Moore evaluated caregiver time use in coordination with a 
clinical trial.  The Caregiver Activities Time Survey (CATS) was used to estimate all 
activities including the administration of medications.  This task was a self-report by the 
caregiver where they were asked to estimate the number of hours and minutes spent in a 
typical day administering medication. While measuring the time that caregivers spend on 
helping with ADLS and certain IADLs is important in understanding caregiver burden, 
managing the patient’s medications is a more complex caregiving process with many 
stressors that should be more clearly defined.   
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2.6. Support of Informal Caregivers 
 
Caregivers require social support from pharmacists, other health care professionals, 
support groups and family members in order to manage medications effectively.  Therefore, 
it is important to examine the medication-related issues of dementia caregivers beyond a 
simple measure of time spent on the activity.  It is also critical to understand the prevalence 
of the individual stressors and examine the support that are currently available to caregivers.  
The dimensions of social support include network structure and social integration, integrated 
social support or enacted support, and subjective social support (Miller and Guo 2000).  
Subjective, or perceived, support has been shown to be the most important type of mediator 
in the caregiving process (Lubben 1988).  Emotional support and help with caregiving 
activities has been shown to be positively associated with lower incidences of caregiver 
stress and depression (Creasey et al 2003; Yates et al, 1999).  The level of social support is 
variable between caregivers depending on both the size and the quality of their social 
network structure.  Thus, this variability can lead to different caregiver health outcomes. 
There are also formal support systems available to caregivers.  Depending on the 
financial status of either the patient or caregiver, there is formal help available in the form of 
home health aides and nurses to assist with caregiving activities in the home.  Only about 
25% of AD patients and caregivers in the United States have the resources to utilize this 
system (Alzheimer’s Association 2006).  However, there are support systems in place that 
could help with caregiving, including medication-related stressors, other than paid 
caregiving.  Caregivers are not always aware of these other formal support systems within 
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the healthcare system which leads to a strain on their emotional health and an increased 
feeling of losing control.   
Pharmacists, support groups and Internet websites are all sources of information for 
medication issues.  Yet, pharmacists seem to be the most logical source for dealing with the 
stressors related to medication management based on their knowledge and consistent contact 
with the patient and/or caregiver give them an advantage over others. The difficulties a 
caregiver faces when managing their loved one’s medications can be reduced with effective 
communication and education from pharmacists.  This research can help in understanding the 
social support needs of the dementia caregiver that can be mediated by pharmacists.  By 
completing this research, we can outline medication-related intervention strategies that will 
decrease caregiver burden and subsequently enhance the health outcomes of both the 
caregiver and the demented patient. 
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2.7. Conceptual Model 
 
Figure 2.1 outlines the basic conceptual framework that shapes this research.  This 
framework was the Stress Process Model of Caregiving and was designed to assess the 
impact of caregiving on overall caregiver health (Pearlin et al 1981; Pearlin et al 1990).  The 
primary reason for choosing this framework was that the model was initially developed by 
applying the stress process model to dementia caregivers.  This model has been used and 
cited in numerous studies involving caregiver emotional health and well-being (Morrissey et 
al 1990; Sisk 2000). As the role of the caregiver changes over time, so does the ability of the 
caregiver to respond to caregiver-related stressors, defined by Pearlin et al as  “problematic 
conditions or difficult circumstances” (Pearlin et al 1990).   
This basic stress process model includes four components: (1) stressors, (2) mediators, 
(3) outcomes, and (4) contextual factors.  Within the conceptual framework presented by 
Pearlin et al (1990), caregivers experience both primary and secondary stressors.  Primary 
stressors are those that are directly linked to the patient and his/her disability while the 
secondary stressors are those that arise from the role of caregiving.  These primary stressors 
can be either objective, and include specific care demands, or subjective (e.g., overload, 
captivity).  Examples of secondary stressors are family conflict, loss of self or inability to 
participate in social activities.  The model assumes the primary stressors directly impact 
emotional health as well as creating secondary stressors (e.g., loss of time for personal 
activities, financial burden).  The caregiving process is complex and there are mediators that 
can influence the stress process.  Social support available to the caregiver as well as their 
confidence in their abilities are potential mediators of the stress process as they have the 
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ability to impact both the stressors and patient reported outcome measurements.  The 
contextual factors that are included in this model are ones that refer to the background of the 
caregiver (e.g., race, gender, education).  Finally, the outcome measurement in this model 
can include both mental and physical health outcomes.   
In this research study, the Pearlin model was modified so that the primary and secondary 
stressors included only the medication management issues of the caregiver.  The 
modifications are shown in Figure 2.2.  By doing this, we were able to directly examine the 
association of medication-stressors on the emotional health outcomes and burden of the 
caregiver while understanding the role of caregiver/care-recipient contextual factors and 
caregivers resources (e.g., support).  Our analyses controls for other caregiving 
characteristics and stressors (e.g., time spent on caregiving tasks, patient functional status, 
comorbidities, and socioeconomic characteristics) that are not specifically outlined in the 
drawing of the conceptual framework but will be discussed in the modeling methodology 
(Chapter 5) and results (Chapter 6).  The caregiver and care-recipient contextual factors are 
important to consider as each caregiver/care-recipient combination is different with 
influences from demographics, relationship and co-habitation status between the caregiver 
and their loved one and the care-recipient’s health and functional status.  The caregiver 
resources are mediator variables in this model as they help to describe the relationship 
between the independent variables (medication related stressors) and the dependent variable 
(caregiver emotional health).  Figure 2.2 shows the mediated relationship with the path 
relating stressors to emotional health outcomes mediated by caregiver resources. 
In the current research study, the primary medication-related stressors are those concerns 
that are related to caring for the demented patient’s medications (e.g., medication 
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administration, dealing with medication side effects and effectiveness of medication therapy, 
acquisition of medications and lack of information).  On the other hand, secondary 
medication-related stressors are encountered as a result of the primary stressors and can be 
measured as caregiver time missed from work or social activities resulting from the 
responsibility of medication management.  The caregiver resources include the support 
available to the caregiver as well as their perceptions of their own financial status and health.  
Social support is measured as the subjective social support and is the extent to which the 
informal caregiver has developed resources to assist in managing the loved one’s medications 
from either family/friends or pharmacists.   
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CHAPTER THREE 
RESEARCH HYPOTHESIS AND SPECIFIC AIMS 
 
The primary research hypothesis was that, among informal caregivers of patients with 
dementia, those who report more medication-related stressors will have poorer emotional 
health outcomes (depression) than those caregivers with fewer medication-related stressors.  
 
The primary aims of this study are: 
Aim 1: To examine the relationship between the medication-related stressors 
experienced by the caregiver and caregiver depression. 
H1: Caregivers who experience more primary medication-related stressors (e.g., 
administering medications, managing side effects of medications) will have more 
depression. 
H2: Caregivers who miss more time from work, leave work early and miss more 
social activities and/or family functions (secondary medication-related stressors) due 
to medication-related problems will have more depression. 
H3: The relationship between the medication-related stressors and caregiver 
depression is mediated by caregiver subjective social support. 
 
Aim 2: To examine the association between the caregiver primary medication-related 
stressors and (a) the caregiver contextual factors and (b) the care-recipient contextual 
factors. 
H4: Caregivers of demented patients with lower functional status and more medical 
comorbidities will have more primary medication-related stressors. 
H5: Caregivers of demented patients on more prescription medications will have more 
primary medication-related stressors. 
H6: Caregivers with less education will have more primary medication-related 
stressors. 
 
Aim 3:  To examine the association between the secondary medication-related stressors 
(e.g, time missed from work, social activities and family functions) of the caregiver and 
(a) the caregiver contextual factors and (b) the care-recipient contextual factors. 
H7: Caregivers of demented patients with lower functional status, more medical 
comorbidities and more medications will miss more time from work, social activities 
and family functions. 
 
The secondary aim of this study is: 
Aim 4: To describe caregivers attitudes about pharmacists and pharmacy services and 
determine what caregivers believe can be done to assist them with medication-related 
stressors. 
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CHAPTER FOUR 
PRELIMIMARY FOCUS GROUPS, DEVELOPMENT AND VALIDATION OF THE 
SURVEY OF CAREGIVER MEDICATION CONCERNS SCALE AND THE 
RESEARCH STUDY QUESTIONNIARE 
 
 This chapter will outline several key components that occurred prior to conducting 
the primary data collection portion of this dissertation research.  First, I will discuss the focus 
groups that were conducted to identify the issues that caregivers face in managing their loved 
one’s medications.  Then, I will discuss how we used the information obtained from the 
focus groups to create a survey instrument for measuring medication-related stressors of 
caregivers.  This will be followed by the scale validation process (item reduction, factor 
analysis, assessment of reliability) that took place after the collection of primary data.  This 
may seem somewhat out of place organizationally as I will not have discussed the process for 
collecting the primary data; however, it will help to keep the process of scale development 
and validation together in one chapter.  Finally, I will conclude the chapter by discussing the 
study questionnaire that was created which includes the survey instrument for medication-
related stressors along with other measurements necessary for testing the research 
hypotheses. 
 
4.1. Preliminary Focus Groups 
 
In order to measure the medication-related stressors of caregivers for the current 
research study, it was necessary to perform some preliminary research and analysis.  The 
Survey of Caregiver Medication Concerns (SCMC) and pharmacy support scales were 
developed from information obtained from focus groups, existing literature, and key opinion 
leaders to elicit information about medication-related issues.  Two focus groups designed to 
explore the difficulties that dementia caregivers face when managing their loved one’s 
medications were conducted with the assistance of the Orange County Department on Aging 
located in Chapel Hill, North Carolina.  The inclusion criteria were:  >18 years of age and 
primary informal caregiver responsible for medication management for their loved one with 
memory problems.  One week prior to the focus group, reminder postcards were sent to 
caregivers who had agreed to participate and a courtesy call was made on the day before to 
confirm.  As an incentive to participate, each caregiver was provided lunch and given a 
twenty-five dollar gift card to Wal-Mart at the end of the session.  The purpose of these 
groups was to identify the medication-related stressors and issues so that the information 
could be used in instrument development.  A script for the focus groups was created based on 
findings from the literature and questions were asked to help identify potential survey items 
(Appendix 1).  Consent was obtained from each participant prior to the focus group.  
Caregivers were informed that they could leave the group at any time if they became 
uncomfortable.  This research was approved by the Institutional Review Board of the 
University of North Carolina at Chapel Hill. 
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Two focus groups were conducted with a total of eighteen informal caregivers of 
patients diagnosed with a memory problem.  Thirteen white and five black caregivers were 
recruited with the assistance of the Geriatric Pharmacy Specialist and social workers at the 
Department on Aging.  The majority of the participating caregivers were female (83%).  The 
groups were diverse in terms of the relationship of the caregiver to the care-recipient with 
spouses (50%), children (22%) and other relatives or friends (28%).  Caregivers reported 
managing, on average, 5.2 prescription medications, for their loved one with memory 
problems. 
There were three primary areas of concern that were identified by the caregivers in 
the focus groups.  First, the caregivers talked about the issues related to administering the 
medications.  The caregivers discussed the difficulties organizing the medications, 
administering more complex therapies (e.g., eye drops, inhalers), coordinating the 
medications appropriately with food, water or milk as needed and convincing the demented 
patient to take the medication.  Second, the caregivers were concerned about their ability to 
both afford and obtain the medications.  All of the caregivers reported going to their 
pharmacy at least three times each month to obtain prescriptions.  The caregivers talked 
about the cost of the prescriptions and that it was becoming increasingly difficult to afford 
them.  One caregiver had not received prescriptions from the physician for her demented 
loved one in the past due to her inability to pay for the drugs.  Eight of the eighteen 
caregivers had researched having their prescriptions shipped from Canada due to cost 
considerations.  Next, the caregivers discussed the role of side effects and medication 
effectiveness as a concern.  The caregivers were concerned about whether or not the 
medication was effective, the need for them (as the caregiver) to determine and communicate 
 24
effectiveness to the demented patient’s physician and their inability to manage side effects 
(e.g., diarrhea). 
Caregivers were also asked questions about pharmacists and pharmacy services.  
They discussed how their pharmacist helped them manage their loved one’s medications and 
also offered suggestions for ways that they could offer additional support.  The primary areas 
of interest in pharmacist and pharmacy support were (1) the availability of information, (2) 
the availability of and access to the pharmacist, and (3) the ability of the pharmacist to work 
closely with their loved one’s physicians on medication-related issues.
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4.2. Scale Development 
 
The focus group sessions were tape-recorded and were then transcribed into text.  The 
audiotapes were erased after transcription.  The content of the transcripts were analyzed by 
the Principal Investigator, a pharmacist, and then reviewed by another pharmacist prior to 
creating the initial item pool.  The item pool was then shared with another group of clinicians 
and key opinion leaders—2 pharmacists, 1 nurse, 2 social workers— from the University of 
North Carolina and Duke University for further review.  The purpose of this review was to 
further examine face validity, identify ambiguous content and edit item content.  Final 
revisions were then made to the item pool and the survey instrument was developed to be 
included in the study questionnaire.     
After the final revisions, a 21-item instrument (Survey of Caregiver’s Medication 
Concerns) which would identify the primary medication-related stressors was ready for 
inclusion in the study questionnaire.  The instrument was divided into three sections and the 
21 items were placed in the most appropriate category:  (1)  eight items related to medication 
administration (e.g., giving medications multiple times per day, managing and organizing 
medications, substitute for performing the task, convincing care-recipient to take 
medications), (2) five items related to medication effects and side effects (e.g., knowing if 
medications are working, identifying adverse events and side effects of medications, 
communicating with patient about medications and problems) and, (3) eight items dealing 
with obtaining and paying for medications (e.g., ability to afford medications, visits to 
pharmacy).  The categories and specific items that comprised this survey instrument are 
listed in Table 4.1. 
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Additional items were added to the study questionnaire to identify secondary 
medication-related stressors and covered time missed from work and social activities and 
times the caregiver was required to leave work early to handle medication problems.  
Secondary related stressors differ from the primary medication-related stressors in that they 
are not directly related to the tasks of managing the medications but are a by-product of the 
process.  For example, managing a side effect (e.g., diarrhea) from the care-recipient’s 
medication regimen is directly related to the medication process (primary medication-related 
stressor) while missing dinner with friends because the caregiver must stay at home with the 
care-recipient is a result of the primary stressor (secondary medication-related stressor).  
These questions address items that were also identified in the focus group conducted in the 
pilot project phase of this research.  Caregivers were asked to recall if they had to miss an 
entire day from work, leave work early or miss a social activity to deal with problems 
associated with managing their loved one’s medications.  Responses were yes/no.  If the 
caregiver responded ‘yes’ to one these three questions, they were asked to recall the number 
of times this had happened within the past 30 days.  The variables identifying the numbers of 
times missed for each of these are continuous variables.  These items are outlined in Figure 
4.1. 
Finally, ten items were developed to measure the caregiver’s perception of their 
current pharmacist and pharmacy services to create a pharmacy support scale.  As with the 
primary and secondary medication-related stressors, these items were also created from 
information obtained during the caregiver focus groups and from a review of the literature.  
Caregivers were asked to indicate their level of agreement with each statement with 
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responses ranging from strongly disagree (score=0) to strongly agree (score=4).  These items 
are outlined in Figure 4.2.   
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Table 4.1:  Primary Medication-related Stressors:  Survey of Caregiver Medication Concerns 
Scale (SCMC) 
 Strongly 
Disagree Disagree Neutral Agree 
Strongly 
Agree 
Administering Medications      
1.  It is hard for me to give my loved one medication 
more than one time a day. 0 1 2 3 4 
2. It is easy to manage my loved one’s medications. 0 1 2 3 4 
3. It is hard to organize all of my loved one’s  
    medications. 0 1 2 3 4 
4. It is easier to keep track of my loved one’s   
    medications when I use a pill organizer. 0 1 2 3 4 
5. I have trouble convincing my loved one to take 
medications. 0 1 2 3 4 
6. It is hard to keep the times of day straight when 
giving my loved one his/her medication. 0 1 2 3 4 
7. I worry about who will give my loved one  
    medication if I am not able to do it. 0 1 2 3 4 
8. There has been a time when I had to hide my loved 
one’s medication. 0 1 2 3 4 
Effects of Medications      
9. I worry at times that my loved one’s medications 
are not working. 0 1 2 3 4 
10. It is hard for me to know whether my loved one is 
having a bad reaction to his/her medications. 0 1 2 3 4 
11. I have trouble managing the side effects (for 
example, nausea, and diarrhea) from my loved 
one’s medications. 
0 1 2 3 4 
12. I am concerned that my loved one is not receiving 
the best medications for his/her condition. 0 1 2 3 4 
13. I worry that my loved one will not be able to let 
me know if the medications are causing problems. 0 1 2 3 4 
Obtaining Medications      
14. I have difficulty, on occasion, paying for my loved 
one’s medication. 0 1 2 3 4 
15. I have, on occasion, decided not to fill a 
prescription for my loved one because money was 
tight. 
0 1 2 3 4 
16. I have, on occasion, decided not to ask my loved 
one’s doctor for a prescription because money 
was tight. 
0 1 2 3 4 
17. There have been times when I have not had 
reliable  transportation to the pharmacy to pick up 
my loved one’s medications. 
0 1 2 3 4 
18. Each month, I have to make more than one trip to 
the pharmacy to pick up medications for my 
loved one. 
0 1 2 3 4 
19. There have been times when my own health has 
prevented me from giving my loved one 
medication. 
0 1 2 3 4 
20. I have considered getting my loved one’s 
medications from outside of the United States 
because they are less expensive there. 
0 1 2 3 4 
21. I worry that I will not be able to afford my loved 
one’s medications in the future. 0 1 2 3 4 
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Figure 4.1  Secondary Medication-related Stressors 
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Figure 4.2  Satisfaction with Pharmacists and Pharmacy Services for Pharmacy Support Scale 
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4.3. Scale Validation 
 
For organizational reasons and since both the primary and secondary medication-
related stressors and pharmacy support are measures included in the multivariable analysis of 
the dissertation, the factor analysis results are included here.  The domains identified in these 
scale validation processes will be used in the methods and results chapters that will follow.  
This may appear to be presented out of order; however, it is important to remember that the 
scale development was a major portion of this dissertation.  For a description of the 
dissertation study questionnaire and the study population in which the scales were tested, 
refer to Chapters 5 and 6, respectively.   
Data from the Survey of Caregiver Medication Concerns (SCMC) and pharmacy 
support portions of the dissertation study questionnaire (n=139) were analyzed using 
descriptive statistics (mean, SD, min, max) to confirm variability among responses.  The 
responses were also examined to verify missing data.  Mean imputation was performed for 
missing values in the medication stressor or pharmacy support items in an effort to preserve 
the number of observations used in the multiple variable modeling and since the amount of 
missing data was small with no more than 2.8% missing from any item.  Any items that 
exhibited either a ceiling or floor effect were considered for elimination from instrument 
validation.   Factor analyses (principal component with Promax rotation) was performed to 
identify the domain structure.  Cronbach’s alpha was calculated to measure internal 
consistency reliability. 
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4.3.1. Survey of Caregiver Medication Concerns Scale 
Item-reduction Analysis:  A descriptive analysis of the original 21-items related to 
medication stressors revealed that there were several items that were subject to either ceiling 
or floor effects where the responses were not well distributed.  Descriptive statistics (mean, 
SD, range) are included in Table 4.2.  The items examined for potential exclusion because of 
abnormal distribution were:  (1) It is easier to keep track of my loved one’s medications 
when I use a pill organizer (mean=3.00, SD=1.27, range 0-4), (2) I have, on occasion, 
decided not to fill a prescription for my loved one because money was tight (mean=0.69, 
SD=0.97, range 0-4), (3) I have, on occasion, decided not to ask my loved one’s doctor for a 
prescription because money was tight (mean=0.63, SD=0.86, range 0-4), (4) There have been 
times when I have not had reliable transportation to the pharmacy to pick up my loved one’s 
medications (mean=0.59, SD=0.84, range 0-4), (5) There have been times when my own 
health has prevented me from giving my loved one medication (mean=0.92, SD=1.14, range 
0-4), and (6) I have considered getting my loved one’s medications from outside the United 
States because they are less expensive (mean=0.98, SD=1.19, range 0-4).  Two other items 
were identified for possible exclusion as well based on their ambiguity:  (1) It is easy to 
manage my loved one’s medications and (2) It is hard to organize my loved one’s 
medications.  The responses were fairly well distributed; however, the questions were not as 
specific as some of the other items and their validity was questioned. 
A correlation matrix was then used to determine correlations among these items with 
ceiling and floor effects to see if there were significant relationships between items that 
would warrant inclusion in the final instrument analysis.   All of the items outlined above 
were correlated with other items in the instrument except for the question about using a pill 
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organizer to manage medications.  Due to the specificity of this item and its relationship to 
being a physical task of organizing the medications, it was chosen for exclusion from the 
factor analysis. 
In addition to some of the responses to items related to the affordability of 
medications not being normally distributed, there was also a concern that the implementation 
of the Medicare Part D prescription drug benefit during the data collection phase might have 
created a bias in these questions.  During development of the items, there was no prescription 
drug benefit under the Medicare program and both the focus groups and literature suggested 
that the cost of medications was a major concern of caregivers.  Since several of the items 
related to affordability were subject to the ceiling and floor effect, we decided to also exclude 
all five items that asked caregivers about paying for medications or their ability to afford 
them.  The following five items were eliminated from the factor analysis:  (1) I have 
difficulty, on occasion, paying for my loved one’s medications, (2) I have, on occasion, 
decided not to fill a prescription for my loved one because money was tight, (3) I have, on 
occasion, decided not to ask my loved one’s doctor for a prescription because money was 
tight, (4) I have considered getting my loved one’s medications from outside the United 
States because they are less expensive, and (5) I worry that I will not be able to afford my 
loved one’s medications in the future.  Once these items were excluded, along with the one 
previously mentioned, there were 15 items available for the factor analysis which will be 
discussed in the next section of this chapter.  These items used in the factor analysis are in 
bold type in Table 4.2. 
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Table 4.2:  Distribution Properties of Original SCMC Scale Items (n=139) 
Question N Mean SD Min Max 
1. It is hard for me to give my loved one medication more 
than one time a day. 135 1.36 1.18 0 4 
2. It is easy to manage my loved one’s medications. 136 2.40 1.18 0 4 
3.  It is hard to organize all of my loved one’s medications. 135 1.41 1.12 0 4 
4. It is easier to keep track of my loved one’s  medications 
when I use a pill organizer. 136 3.00 1.27 0 4 
5. I have trouble convincing my loved one to take 
medications. 136 1.34 1.28 0 4 
6. It is hard to keep the times of day straight when giving 
my loved one his/her medication. 136 1.14 1.09 0 4 
7. I worry about who will give my loved one  
    medication if I am not able to do it. 136 2.27 1.34 0 4 
8. There has been a time when I had to hide my loved 
one’s medication. 136 1.46 1.42 0 4 
9. I worry at times that my loved one’s medications are 
not working. 136 2.24 1.06 0 4 
10. It is hard for me to know whether my loved one is 
having a bad reaction to his/her medications. 136 1.92 1.19 0 4 
11. I have trouble managing the side effects (for example, 
nausea, and diarrhea) from my loved one’s 
medications. 
136 1.41 1.09 0 4 
12. I am concerned that my loved one is not receiving the 
best medications for his/her condition. 136 1.58 1.06 0 4 
13. I worry that my loved one will not be able to let me 
know if the medications are causing problems. 136 2.54 1.22 0 4 
14. I have difficulty, on occasion, paying for my loved one’s 
medication. 136 1.32 1.16 0 4 
15. I have, on occasion, decided not to fill a prescription for 
my loved one because money was tight. 136 0.69 0.97 0 4 
16. I have, on occasion, decided not to ask my loved one’s 
doctor for a prescription because money was tight. 136 0.63 0.86 0 4 
17. There have been times when I have not had reliable 
transportation to the pharmacy to pick up my loved 
one’s medications. 
135 0.59 0.84 0 4 
18. Each month, I have to make more than one trip to the 
pharmacy to pick up medications for my loved one. 136 2.13 1.45 0 4 
19. There have been times when my own health has 
prevented me from giving my loved one medication. 136 0.92 1.14 0 4 
20. I have considered getting my loved one’s medications 
from outside of the United States because they are less 
expensive there. 
136 0.98 1.19 0 4 
21. I worry that I will not be able to afford my loved one’s 
medications in the future. 136 1.69 1.37 0 4 
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Factor Analysis:  A factor analysis was performed on the remaining 15 items from 
the instrument which met the factor analysis requirement of having between 5 to 10 subjects 
per item as there were 139 caregivers in the study population (Tinsley HE, 1987).  Principal 
component analysis with Promax rotation revealed five factors with Eigenvalues >1.  
Eigenvalues of the correlation matrix for this analysis are shown in Table 4.3 and the 
corresponding scree plot is illustrated in Figure 4.3.  The scree plot shows a break between 
one and two factors.  Upon examination of the scree plot, it was determined that two 
components captured approximately 40% of the variance in the model with 30% and 10% 
explained by the first and second factors, respectively.  While this information helped to 
guide the decision about how many common factors to retain, I also examined the 
interpretability of the two factor solution.   
After performing a Factor Analysis retaining two factors, I looked at (1) the 
simplicity of the two factor structure and (2) how well the variables fit together conceptually.  
The factor loadings (Table 4.4) suggested a simple factor structure with variables having 
moderate to high loadings (coefficient ≥ 0.40) on one construct and low loadings on the other 
construct.  Finally, the items within each of the constructs were examined to determine 
whether or not they were conceptually similar within the same construct and distinctively 
different from the other construct.  The items under each construct followed the original 
concept introduced and developed in the focus groups and the preliminary analysis.  All of 
the items that were identified previously as concerns with effects and effectiveness of 
medications were within the medication effects construct of the two factor solution while all 
of the items related to administering and obtaining medications were within the medication 
administration construct.  Therefore, two domains were identified—medication 
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administration and medication effects—to be used for measuring the primary medication-
related stressors.   
The ten items loading on medication administration included:  (1) there have been 
times when my own health has prevented me from giving my loved one medication, (2) it is 
hard to keep the times of the day straight when giving my loved one his/her medication, (3) 
there has been a time when I had to hide my loved one’s medication, (4) I worry about who 
will give my loved medication if I am not able to do it, (5) each month I have to make more 
than one trip to the pharmacy to pick up medications for my loved one, (6) it is hard to give 
my loved one medication more than one time a day, (7) there have been times when I have 
not had reliable transportation to the pharmacy to pick-up my loved one’s medications, (8) I 
have trouble convincing my loved one to take medications, (9) It is easy to manage my loved 
one’s medications, and (10) It is hard to organize all of my loved one’s medications.  The 
five items loading on medication effects were:  (1) it is hard for me to know whether my 
loved one is having a bad reaction to his/her medications, (2) I worry at times that my loved 
one’s medications are not working, (3) I have trouble managing the side effects from my 
loved one’s medications, (4) I am concerned that my loved one is not receiving the best 
medications for his/her condition, and (5) I worry that my loved one will not be able to let me 
know if the medications are causing problems.  The correlation between the two domains 
was 0.49 (p<0.0001). 
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Table 4.3:  Eigenvalues of the Correlation Matrix (Promax Rotation) for SCMC (15 items) 
 
Factors Eigenvalue Proportion of Variance Cumulative Variance  
1 4.42597456 0.2951 0.2951 
2 1.48593653 0.0991 0.3941 
3 1.27500592 0.0850 0.4791 
4 1.13218215 0.0755 0.5546 
5 1.04695125 0.0698 0.6244 
6 0.87550258 0.0584 0.6828 
7 0.81033340 0.0540 0.7368 
8 0.75356335 0.0502 0.7870 
9 0.62997767 0.0420 0.8290 
10 0.59488962 0.0397 0.8687 
11 0.48276161 0.0322 0.9009 
12 0.44676983 0.0298 0.9307 
13 0.40481475 0.0270 0.9576 
14 0.32703432 0.0218 0.9794 
15 0.30830248 0.0206 1.000 
 
 
 
Figure 4.3:  Scree Plot of Eigenvalues for SCMC (15 items) 
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Table 4.4:  Factors Loadings (Promax) of SCMC Scale (15 items) 
 
Item Focus 
FACTOR 1 
Medication 
Administration 
FACTOR 2 
Medication 
Effects 
Own health has prevented from giving medications. 0.674 -0.052 
Hard to keep the times of day straight for administering. 0.609 0.102 
Had to hide loved one’s medications. 0.606 -0.176 
Multiple trips to the pharmacy each month. 0.590 -0.235 
Hard to organize medications. 0.545 0.240 
Worry about who will give medications if he/she unavailable. 0.532 0.127 
Hard to give medications more than once per day. 0.446 0.242 
No reliable transportation to pharmacy at times. 0.444 0.117 
Trouble convincing loved one to take medication. 0.401 0.263 
Easy to manage loved one’s medications. -0.498 -0.174 
Hard to identify adverse reactions to medications. -0.116 0.819 
Worry that medications are not working. -0.056 0.734 
Trouble managing the side effects of medications. -0.007 0.646 
Concerned that loved one not receiving best medications. 0.072 0.627 
Worry that loved one can not communicate problems with 
medications. 0.069 0.602 
 
 
Internal Consistency:  Cronbach’s α for both factors exceeded the standard criterion 
for reliability of ≥ 0.70 with values for medication administration and medication effects 
being 0.77 and 0.74, respectively.  Table 4.5 shows the reliability estimates along with the 
distribution of the factors.  Since this was a study questionnaire administered at one single 
point in time with no follow-up surveys, it was not possible to perform test-retest reliability 
within the scope of this dissertation. 
 
Table 4.5:  Reliabilities and Descriptive Statistics of Factors 
 
Factor N # of Items Mean SD Range Cronbach α 
Factor 1 
Medication 
Administration 
133 10 14.21 6.91 0-31 0.77 
Factor 2 
Medication 
Effects 
136 5 9.68 3.91 0-20 0.74 
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4.3.2. Pharmacy Support Scale 
Item-reduction Analysis:  A descriptive analysis of the 10-item pharmacy support 
scale that measured caregiver’s perception of pharmacists and pharmacy services revealed 
that there were no items subject to either floor or ceiling effects.  Therefore, all items 
remained in the scale for factor analysis and the test for reliability.  Descriptive statistics for 
these items are in Table 4.6.   
 
Table 4.6: Descriptive Statistics for the Pharmacy Support Scale (n=133) 
 
    
 Mean SD Range 
The pharmacist is usually available to answer 
my questions about my loved one’s 
medications. 
2.96 0.96 0-4 
    
The pharmacist warns me about problems that 
my loved one might have with the 
medications. 
2.29 1.21 0-4 
    
The pharmacist tells me what my loved one’s 
medications are used for. 2.17 1.22 0-4 
    
I receive advice from the pharmacist that helps 
me to manage my loved one’s medications. 2.21 1.17 0-4 
    
The pharmacist answers any questions that I 
have about my loved one’s medications. 2.88 0.96 0-4 
    
I feel like the pharmacist really cares about my 
overall health and well-being. 2.37 1.14 0-4 
    
There is a place at the pharmacy where I can 
talk in private with the pharmacist. 1.81 1.22 0-4 
    
I am satisfied with the amount of time that the 
pharmacist spends with me. 2.37 1.07 0-4 
    
I trust the pharmacist to give me the best 
information about my loved one’s 
medications. 
2.67 1.05 0-4 
    
The pharmacist works with my loved one’s 
doctors to provide the best medications 
possible. 
2.10 1.05 0-4 
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Factor Analysis:  A factor analysis was performed on the 10-item pharmacy support scale.  
As with the SCMC, this instrument met the factor analysis requirement of 5 to 10 subjects 
per item.  Principal component analysis revealed only one factor with an Eigenvalue >1.  
Eigenvalues from this analysis are shown in Table 4.7 and the corresponding scree plot is 
demonstrated in Figure 4.4.  The one-factor solution revealed high factor loadings (>0.50) 
with these values shown in Table 4.8. 
 
Table 4.7:  Eigenvalues of the Correlation Matrix for Pharmacy Support Scale (10 items) 
 
Factors Eigenvalue Proportion of Variance Cumulative Variance  
1 6.50804977 0.6508 0.6508 
2 0.96592009 0.0966 0.7474 
3 0.79139692 0.0791 0.8265 
4 0.46387960 0.0464 0.87298 
5 0.30787003 0.0308 0.9037 
6 0.25586933 0.0256 0.9293 
7 0.20984168 0.0210 0.9503 
8 0.20180943 0.0202 0.9705 
9 0.16617894 0.0166 0.9871 
10 0.12918332 0.0129 1.000 
 
 
Figure 4.4:  Scree Plot of Eigenvalues for Pharmacy Support Scale (15 items) 
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Table 4.8:  Factors Loadings of Pharmacy Support Scale (10 items) 
 
Item Focus Factor Loading 
Pharmacist cares about caregiver’s overall well-being 0.899 
Receive advice from pharmacist that helps manage medications. 0.865 
Satisfaction with the amount of time spent with pharmacist. 0.860 
Pharmacist explains what medications are used for. 0.843 
Pharmacist warns about medication problems. 0.830 
Trust the pharmacist to give the best information about medications. 0.827 
Pharmacist works with doctor to provide best medications.  0.799 
Pharmacist answers questions about medications. 0.791 
Pharmacist available to answer questions. 0.730 
Private place at the pharmacy to talk to pharmacist. 0.575 
 
Internal Consistency:  Cronbach’s α for the one-factor solution was 0.94.  Table 4.9 
shows the reliability of the scale along with the distribution of the scores.  As with the 
SCMC, it was not possible to perform test-retest reliability with this cross-sectional survey of 
caregivers. 
 
Table 4.9:  Reliabilities and Descriptive Statistics of Pharmacy Support Scale 
 
Factor N # of Items Mean SD Range Cronbach α 
Pharmacy 
Support 133 10 23.79 8.94 0-40 0.94 
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4.4. Research Study Questionnaire 
 
Most surveys of dementia caregivers, including the National Longitudinal Caregiver 
Sample conducted in caregivers of veterans with AD and vascular dementia, have only 
measured the medication-related activities of the caregiver in terms of time spent on the 
caregiver activity using a caregiver activities time survey.  There was no public or private 
dataset available for use in this study that had measured specific medication-related concerns 
of caregivers of demented patients.  In order to achieve the specific aims outlined in this 
proposal, it was necessary to perform primary data collection.  A self-report study 
questionnaire was designed to collect all of the information to examine the proposed 
conceptual framework outlined in Chapter 2 (Section 2.7).   
Using existing literature, key opinion leaders and results from the SCMC instrument 
development, a study questionnaire, Caregivers of Persons with Memory Problems: The 
Medication Study, was designed as a caregiver self-report survey to elicit caregiver and care-
recipient contextual information (e.g, demographics, health status), medication-related 
stressors (e.g, issues with administering medications, managing effects and side effects of 
medications, obtaining prescription medications), social support (e.g., family members, 
friends, pharmacists) and emotional health outcomes (e.g., depression).  The overall process 
will be outlined in this section and will be followed by sections that detail the data elements 
collected and the analysis performed.  
An initial list of data elements was created that included all of the variables required 
for analysis (outlined in Chapter 3).  For each data element, we determined the number(s) of 
questions needed to obtain the necessary information and whether or not we would create the 
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question(s) or use survey instruments that had been proven reliable and valid in previous 
research.  Each of these data elements were grouped into one of four categories based on the 
conceptual model: (1) caregiver and care-recipient contextual information, (2) caregiver 
resources, (3) medication-related stressors, and (4) caregiver emotional health outcomes.  
The source, question/item construction, range of responses, and reliability/validity 
information for each of the items organized under these four categories are detailed in the 
Measurement section of Chapter 5 (Section 5.3). 
Once all necessary items were identified, a draft questionnaire was circulated to a 
group of survey experts for feedback.  This group included three pharmacists, one nurse, two 
social workers and a statistician—all who had experience and familiarity with survey 
research methodology and questionnaire development.  The process from this point was an 
iterative one with adjustments being made to improve the consistency of questions, to 
enhance the readability and understandability, and to eliminate or correct ambiguous 
questions.  Most of the changes to the survey were minor changes in wording or structure of 
questions.  However, a few key things were done to improve the appeal of the questionnaire 
and to provide a positive frame of reference for the survey respondent (caregiver).  First, the 
term “loved-one” was eliminated from the questionnaire in as many places as possible and 
replaced with the term “care-recipient.”  This was done because “loved one” often has 
different meanings to different caregivers.  Next, the term “dementia” and “demented 
patient” were removed from the entire survey and replaced with “memory problems” and 
“persons with memory problems.”  Again, this was done in an effort to soften the tone of the 
survey.  Finally, a blank page was included at the end of the survey that asked the caregiver 
to share any additional thoughts or ideas that they had about managing the care-recipients 
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medications or the caregiving process, in general.  This opportunity, along with a note of 
appreciation, helped to leave the caregiver with a positive feeling about their participation.  
Once all changes had been made, one final draft showing the comments and changes was 
sent to all reviewers for final approval prior to printing.  
This final draft was also shared with three caregivers who had participated in the 
focus groups to determine the time required to complete the questionnaire.  On average, it 
took these caregivers 16 minutes to answer all of the questions.  This seemed appropriate and 
was not considered too burdensome from a time perspective.  The final questionnaire was 
prepared in a 12-point font for ease of reading and then printed and bound into a booklet 
format.  The final version of the questionnaire is in Appendix 2. 
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CHAPTER FIVE 
METHODS 
 
5.1. Study Population 
 
Adults who were primary informal caregivers of persons with memory problems were 
the targeted population for this research study.  While there was no medical record review of 
the care-recipient to confirm the diagnosis of memory problems, caregivers were asked to 
self-report whether or not the care-recipient had received a formal diagnosis of either AD, 
vascular dementia or another form of memory problem.  In order to participate in the study, 
the caregivers were required to (1) be > 18 years old, (2) be able to read and write in English, 
(3) be the primary informal caregiver for the demented patient, and (4) be responsible for 
medication administration and/or management for the care-recipient. Adult caregivers who 
are the primary caregiver for the demented patient are at highest risk for poorer mental and 
physical health outcomes (Clipp and Moore 1995).  Thus, the targeted population represented 
an appropriate high-risk group.  Caregivers who participated in the pilot phase of this project 
(focus groups) where the SCMC and pharmacy support scales were developed (outlined in 
Chapter 4) were not eligible to participate in this formal research study.  This research was 
approved by the Institutional Review Board of the University of North Carolina at Chapel 
Hill. 
5.2. Caregiver Recruitment and Data Collection 
 
Caregivers of persons with memory problems were recruited using several 
partnerships that were developed by the Principal Investigator.  There were four primary 
sources of caregivers:  (1) Geriatric and Memory Disorder clinics within the medical center 
at the University of North Carolina at Chapel Hill, (2) Eastern and Western North Carolina 
Chapters of the Alzheimer’s Association, (3) local, county and regional Departments on 
Aging and Councils on Governments throughout the state of North Carolina, and (4) an 
online caregiver support group, “The Alzheimer’s List 
(http://alzheimer.wustl.edu/adrc2/alzheimerlist/).”    These resources were targeted because 
they each allowed direct access to a group of primary informal caregivers of persons with 
memory problems, either through patient/caregiver visits with a physician or in a caregiver 
support group setting.  It was believed that this strategy would also offer diversity and 
provide access to caregivers from a range of socioeconomic backgrounds.   
The Principal Investigator (PI) communicated initially with each key contact at these 
organizations, either by telephone or electronic mail, to introduce the research study.  If the 
identified contact person was not responsible for interactions with the dementia caregivers, 
the PI was given the appropriate contact information and approached those individuals.  Once 
the appropriate contact person was identified, more detailed telephone conversations or face-
to-face meetings were held to outline the purpose of the research study and develop a 
strategy for making contact with caregivers.  Each support group and organization was 
structured differently and specific contact strategies were needed for each partnership 
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opportunity.  Certain support groups would allow presentations, others would only permit a 
brief explanation of the study and others did not allow outside participation at all. 
Between December 2005 and August 2006, the Principal Investigator spent time with 
caregivers during clinic visits, visited eleven caregiver support groups through the state of 
North Carolina, worked with three other support groups who would not allow personal visits 
by mailing a packet of surveys and posted two requests (one month apart) on “The 
Alzheimer’s List” listserv requesting caregivers to participate.  The UNC Geriatric and 
Memory Disorders clinics were visited one day a week for a total of three months (January-
March in Geriatric clinic; May-July in Memory Disorders clinic).  The caregivers were 
approached about the research study after the physician or multidisciplinary team had seen 
the patient.  The visits to each clinic were discontinued after three months because of the 
decrease over time in the number of eligible participants due to earlier participants returning 
for follow-up visits. 
Caregiver support groups were offered an educational program entitled, Medications 
and Memory Problems.  The program outlined the basic categories of prescription and over-
the-counter medications used in treating patients with dementia and provided useful tips for 
helping the caregiver better manage the medication process.  The Principal Investigator, a 
pharmacist, presented this program during a scheduled support group in return for the 
opportunity to introduce the research study and distribute study questionnaires to interested 
caregivers.   Three caregiver support groups were unable to coordinate a meeting time for the 
program or the facilitator did not allow presentations during their meeting time.  For these 
groups, the caregiver facilitators were sent a packet of surveys to distribute to their caregivers 
during their meeting.  
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Using all of these resources, a total of 189 caregivers were contacted and provided 
with a study questionnaire. As an incentive for completing the study questionnaire and to 
maximize response, all study caregivers who returned a completed survey were sent a check 
for fifteen dollars.  The initial survey packet (study questionnaire, cover letter, informed 
consent form and contact card) was distributed to the caregivers in various manners 
depending on the type of contact with the caregiver.  For caregivers who were given the 
packet during a clinic visit or at support group meeting, the PI collected contact cards and 
signed informed consent forms at the time of distribution.  For the three support groups 
where the PI was not present at the meeting, the meeting facilitator followed the same 
distribution process as the PI.  Completed contact cards and informed consent forms were 
mailed to the PI for follow-up.  If the caregiver was recruited over the online listserv, the 
initial packet was mailed to the caregiver with a detailed instruction sheet that asked them to 
return the signed consent form with their completed survey.  Contact information for these 
caregivers was obtained by electronic mail.  All caregiver contact information was loaded 
into a secure, password-protected database so that the information could be used for follow-
up procedures.   
To maximize survey response rate, procedures recommended by Dillman was used 
(Dillman 2000).  Each study questionnaire that was initially given to a caregiver was 
accompanied by a personalized cover letter reinforcing the importance of the study and 
thanking the caregiver for participating.  A self-addressed stamped envelope was included 
with the study questionnaire.  One week after the caregiver was given a study questionnaire; 
he/she was sent a letter thanking them for participating in the study and reminding them to 
return the questionnaire, if they have not already done so.  If the study questionnaire had not 
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been returned within three weeks of them receiving it, caregivers were sent a letter 
encouraging them to complete the questionnaire and return it to us at their earliest 
convenience.  A replacement questionnaire and self-addressed, stamped return envelope was 
included with the letter.  If the questionnaire had not been returned within eight weeks of 
initially receiving it, caregivers were sent a similar follow-up packet.  Caregivers who did not 
return the questionnaire after the eight-week mailing were contacted by telephone or email, 
depending on the contact information available, to determine if they were still interested in 
participating in the study.  If the participant was no longer interested in participating, no 
further follow-up was conducted.  If they were interested in participating, a final study 
questionnaire was mailed to the caregiver.  No further contact was made with the caregiver 
after this mailing.  Each letter used throughout the follow-up process is located in Appendix 
3. 
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5.3. Measurements 
 
 This section will outline the four categories of data collected in the study 
questionnaire, Caregivers of Persons with Memory Problems: The Medication Study.  The 
first category is caregiver and care-recipient contextual information.  This category includes 
sociodemographic variables (background and context) for both the caregiver and care-
recipient and medical/functional status of the care-recipient.  Next, information about 
caregiver resources is categorized to describe their subjective social support, their health 
status, their perceived financial adequacy, and their satisfaction with pharmacists and 
pharmacy services.  Third, the medication-related stressors that were experienced by the 
caregiver are defined.  This category included instrument development as there was no 
current survey tool available.  Complete details of the development of this scale were 
detailed in Chapter 4.  This section will also include the 10 items asked about satisfaction 
with pharmacist and pharmacy services.  Finally, the caregiver emotional health outcome 
(depression), which is the critical endpoints of the conceptual model, is detailed.  This 
section is inclusive of all items and measures in the study questionnaire regardless of their 
inclusion in the analyses required for the research study.  Specific measures that were 
modeled in the multivariable analyses are discussed in the Data Analysis section (Section 
5.4) of this chapter. 
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5.3.1. Caregiver and Care-recipient Contextual Information 
 Sociodemographics:  The following variables were collected for both the caregiver 
and care-recipient: age, gender, ethnicity (American Indian/Alaskan, Asian, Black/African 
American, Native Hawaiian or Pacific Islander, White, Hispanic/Latino), marital status 
(married, separated, divorced, widowed, never married), and education level (less than high 
school, high school diploma or more).  Information was also asked about how long the 
caregiver had been caring for the care-recipient, cohabitation with the care-recipient (yes=1; 
no=0), and whether or not he/she was a caregiver for someone else (yes=1; no=0).  Age and 
length of time as a caregiver were continuous variables.  The categorical variables for 
ethnicity and marital status were dichotomized and the caregivers were described as being 
White or non-White and married or not married.   
Care-recipient Medical Comorbidities:  The number of comorbid conditions was 
captured using the Older American Resources and Services (OARS) comorbidity scale, 
which asked the caregivers to indicate the presence (yes) or absence (no) of 25 medical 
conditions (Haley et al 1996).   One additional item (the presence of pain) that was not 
included in the original survey was added to the list of comorbidities.  Comorbid 
psychosocial symptoms including pain are prevalent in the demented elderly; therefore, we 
thought that it was important to add this item to the comorbidity scale (Snow A 2005).  The 
caregiver was asked to report the number of conditions for their loved one.  The score was 
summed for a possible range of 0-26 with a higher value indicating the presence of more 
medical comorbidities. 
 Care-recipient Functional Status:  The number of IADLs that could be performed 
independently by the demented patient was measured using part of the OARS 
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Multidimensional Functional Assessment questionnaire (Fillenbaum 1988).  The OARS 
IADL instrument consists of seven items that measure the help needed by the demented 
patient for instrumental activities of daily living.  Each item was given a score of 1 to 3 
resulting in a possible range of 7 to 21 with higher scores indicating a higher level of 
assistance needed. 
 Care-recipient Medications:  The caregiver was asked to recall the number of 
prescription medications that the care-recipient was taking at the time of the survey and was 
directed to retrieve the bottles and count the number of medications, if necessary, in order to 
provide an accurate count.  Instructions were also given to exclude any over-the-counter or 
herbal medications.  The number of medications was a continuous variable.  Caregivers were 
also asked whether or not their care-recipient was covered by prescription drug insurance.  
The responses (yes=1; no=0) created a dichotomous variable.  If the caregiver responded 
‘yes’ to this question, they were asked to indicate which type of insurance coverage based on 
the following categories:  private insurance, Medicaid, Veterans Administration, Medicare or 
other.  Caregivers were also asked to indicate the number of pharmacies that they routinely 
used for obtaining prescription medications and this variable was continuous.  The names of 
the pharmacies used by the caregivers were listed and categorized by the PI into one of three 
categories:  chain, independent, or mail order pharmacy. 
Table 5.1 presents a summary of care-recipient and caregiver contextual 
measurements included in the research study questionnaire. 
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Table 5.1: Summary of Care-recipient and Caregiver Contextual Information Measurements 
 
Variable Type/Range 
Care-recipient 
Number of patient comorbidities 0-26; discrete 
Patient IADLs 7-21; discrete 
Age Continuous 
Gender Dichotomous 
Ethnicity Dichotomous 
Number of prescription medications Discrete 
Caregiver 
Age Continuous 
Gender Dichotomous 
Ethnicity Dichotomous 
Education  Dichotomous 
Marital Status Dichotomous 
Caregiver for Others Dichotomous 
Lives with care-recipient Dichotomous 
Length of time as caregiver Continuous 
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5.3.2. Stressors 
The concerns with medication management were measured in two ways—primary 
and secondary medication-related stressors.  Primary medication related-stressors were 
measured using the two factors identified in the SCMC scale development (Chapter 4).  
Those two factors were medication administration (10 items) and medication effects (5 
items).  Each item within the two factors was scored from 0-4 with a range of 0-40 for 
medication administration and 0-20 for medication effects.  A higher score represented a 
greater level of concern or burden within that domain.  These scales were found to be reliable 
as presented in Chapter 4 (Section 4.3.2) with a Cronbach’s alpha of 0.77 for medication 
administration and 0.74 for medication effects.   
Secondary medication-related stressors were measured by asking three questions 
that inquired about missing an entire day of work, leaving work early, or missing a social 
activity within the past 30 days to deal with problems associated with managing the care-
recipient’s medications.   Responses were yes/no and the variables were dichotomous.  If the 
caregiver responded ‘yes’ to one of these questions, they were asked to report the number of 
times within the past 30 days that this had occurred. 
Caregiver Activity Survey:  While it is important to understand the specific 
medication-related stressors of caregivers, it remains important to evaluate the time that 
caregivers spend on their caregiving tasks.  This study questionnaire included the Caregiver 
Activity Survey (CAS) that measured the time spent caring for the person with memory 
problems (Davis et al 1997).  The instrument covers six areas of caregiving activities—
communicating with the person, using transportation, dressing, eating, looking after one’s 
appearance and supervising the person—and asks the caregiver to anticipate, on average, the 
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time spent performing the task in a typical 24-hour period.  The reports of time spent on the 
activities were summed to create one ‘time’ variable that represented the total time spent on 
caregiving.  If caregiver responses yielded a total time measurement that exceeded the 24 
hour period, the total time was capped at 24 hours for the purposes of modeling.  The six-
item CAS total score has high test-retest reliability, with ICC = 0.88 between weeks 1 and 3 
(Davis et al 1997).  Convergent validity was also tested by Davis et al in 1997 by assessing 
the correlation between the CAS and other AD measures—Alzheimer’s Disease Assessment 
Scale Cognitive Subscale (ADAS-Cog), Mini Mental State Exam (MMSE), and Physical Self 
Maintenance Scale (PSMS).  The CAS total time scores were found to be positively 
correlated with ADAS-Cog and PSMS with r=0.69 (p<0.0001) and r=0.51 (p<0.0001), 
respectively.  The total time scores were found to be negatively correlated with the MMSE 
(r=-0.63; p<0.0001). 
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5.3.3. Caregiver Resources:   
Social Support:  Caregiver social support was measured using a modified, 11-item 
version of the Duke Social Support Index (DSSI) that measures subjective social support 
(Koenig et al 1993).   The seven items that are related to subjective social support of the 
caregiver were summed to create the support measure.  Items were scored on a scale of 1 to 3 
resulting in a total score range of 3-21 with higher scores indicating a higher level of 
subjective social support.  One question, related to the satisfaction of the caregiver with their 
kind of relationships with their family and friends, required reverse scoring; otherwise, all 
other questions were scored based on the caregiver’s responses in the study questionnaire.  
There were no weights required for items when scoring.  Internal consistency, using 
Cronbach’s alpha, has been reported in different types of populations and ranges between 
0.71 and 0.81 (Koenig, 1993). 
Caregiver Self-reported Health:  Caregiver perceived health status was measured 
using the SF-12 Health Survey.  The short version was used to limit respondent burden and it 
provides a reliable estimate of caregiver perceived health status.  This instrument has been 
proven to be both valid and reliable with Cronbach’s alpha of 0.91 (Ware et al 1996).  The 
SF-12 includes a physical component (e.g., physical functioning, bodily pain, general health) 
and a mental component (e.g., vitality, social functioning, emotional and mental health) and 
two scores were reported with a range from 0 to 100 for each where a higher score indicates 
better health.  Scoring was performed using the online scoring software for SF12-v2 
(QualityMetric, Inc.) and the accompanying scoring algorithms.  This scoring tool includes 
algorithms that handles missing responses and computes the scale and summary scores 
without deleting observations. 
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Perceived financial adequacy:  This was measured using three questions that assess 
the degree to which bills are burdensome, the degree to which money meets their basic needs 
and the adequacy of income to buy extras (Fillenbaum 1998).  Responses were measured on 
a 3-point scale with a possible range from 1 (low financial well-being) and 3 (high financial 
well-being).  The items were summed for a range of scores from 3-9.  There was no 
weighting or reverse scoring required for this measurement.  This variable was used to 
indicate the caregiver’s perceived financial adequacy. 
Pharmacy Support:  Ten items were included in the study questionnaire to assess the 
caregiver’s perceptions of their pharmacist and pharmacy.  The primary areas covered by 8 
of the 10 questions included availability of and communication and interaction with the 
pharmacist.  The other two questions focused on the privacy of consultation within the 
pharmacy and the pharmacist’s relationship with their care-recipient’s physician(s).  Each of 
these items were scored on a scale of zero (strongly disagree) to 4 (strongly agree) with 
higher scores representing a higher level of perceived satisfaction with their current 
pharmacy and pharmacy services.  All ten items were shown to be highly correlated to one 
another which resulted in a one-factor solution in the scale validation process described 
previously (Section 4.3.2).  The scale was reliable with Cronbach’s α=0.94.  All ten items 
were summed to create a continuous variable with a possible range from 0 to 40.  
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5.3.4. Caregiver Emotional Health Outcome 
The standardized instrument included in the questionnaire to measure the emotional 
health outcome of the caregiver was the abbreviated version of the Patient Health 
Questionnaire (depression presence and severity). 
Depression:  The abbreviated version of the original Patient Health Questionnaire 
(PHQ-9) was included to assess depression presence and severity.  The PHQ is a self-
administered depression module of the PRIME-MD diagnostic instrument for common 
mental disorders.  This version consists of the actual criteria upon which the diagnosis of the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Editions (DSM-IV) 
depressive disorders is based.  The module presents nine depressive symptoms.  Respondents 
were asked to recall the past two weeks and score the presence of each symptom on a scale 
from 0 to 3 (0=not at all; 1=several days; 2=more than half the days; 3=nearly every day).   
The scores for each item of the nine items are summed to create an overall score range of the 
PHQ-9 is 0 to 27.  Higher scores represent a greater level of depression presence and 
severity.  None of the items require reverse scoring nor are there any weights applied to any 
of the items.  Using this instrument, depression presence and severity can also be categorized 
as minimal (score 0-4), mild (score 5-9), moderate (10-14), moderately severe (15-19) and 
severe (score ≥20) (Kroenke, 2001).   
This shorter version of the PHQ was used since it has been shown to be equally valid 
and reliable as the longer version to measure depression severity (Kroenke, 2001).  Criterion 
validity has been performed by using an independent Mental Health Professional (MHP) 
interview as a standard.  For PHQ-9 scores greater than or equal to 10 (indicating at least 
moderate depressive severity) there was a sensitivity of 88% and a specificity of 88% for 
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major depression using the MHP as the criterion standard (Kroenke, 2001).  Cronbach’s 
alphas ranging from 0.86 to 0.89 have been reported in studies within a variety of practice 
settings (Spitzer, 1999; Spitzer, 2000).   
In order to obtain information about things that the caregivers were currently doing to 
alleviate depressive feelings or symptoms, a series of questions were developed.  First, one 
general question, “In the past 2 weeks or so, have you been feeling sad or depressed or no 
interest in things,” was asked.  This question was not included to either replace the PHQ-9 
measurement or to be used in conjunction with it.  It was only included to solicit information 
about strategies being employed by caregivers to manage their feelings of being “sad, 
depressed or no interest in things” and is used for descriptive purposes only for this study and 
for purposes of future research.  If the caregiver responded ‘yes’ to this question, they were 
then asked what types of things they were currently doing to help them get over these 
feelings.  The following options were given to solicit this information from the caregiver: (1) 
nothing, (2) taking an antidepressant medication, (3) taking herbal medicines or natural 
supplements, (4) getting counseling from a mental health professional, (5) getting counseling 
from a health care provider, (6) going to a support group, and (7) talking with someone at 
church.  
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5.4 Data Analysis 
 
5.4.1. Preliminary Analysis 
All data analysis was performed using SAS Version 9.1 (Cary, North Carolina) after 
converting the dataset from the SPSS program where the data were entered.  Preliminary 
analysis was performed to clean the data, assess violations of assumptions, and identify 
potential confounders. Descriptive analyses were performed to describe the sample.  The 
distributions of variables to be used in the primary analyses were also examined.  
Frequencies and percents were used to summarize categorical measures, and means, standard 
deviations, ranges and frequency plots were used to describe continuous measures.  Bivariate 
relationships were assessed using t-tests, correlations, and chi-square statistics. 
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5.4.2. Outliers/Missing Data 
Steps were taken to (1) ensure data integrity and appropriateness and (2) to 
understand the missing data patterns and impute missing data.  The first step to ensure the 
integrity and appropriateness of the data was to check the accuracy of the data coding and the 
entry into the computer program (SPSS).  This was done by pulling a random sample of 25% 
of the original study questionnaires (n=35) and comparing the data that was entered into the 
computer database to the responses that were on the hard copies.  There were no 
discrepancies identified.  The entire dataset was then scanned for values that were outside of 
the ranges for the variables.  There were was a 3% error in cases (4 out of 139 
questionnaires) where a data point was outside of the appropriate range.  The hard copy 
questionnaires were pulled to examine the responses.  In each one of the cases, the data had 
been entered incorrectly into the database.  Each of the errors was corrected and the final data 
was found to lie within the necessary parameters. 
Following the test for integrity and accuracy, the data was then scanned for missing 
data and it was determined that the proportion of missing data for any of the dependent or 
independent variables that were being modeled was less than 5%.  The data was also scanned 
to determine if there were trends in the missing data that indicated that an item was subject to 
refusal of reporting.  The majority of the data that was missing was done by the respondent 
not completing an entire page of the study questionnaire or not finishing the questionnaire.  
Before deciding on the method for handling the missing data, it was necessary to determine if 
the data were missing at random.   In order to test this, the respondents were divided into two 
groups:  (1) those with missing responses (n=40) and (2) those without missing responses 
(n=99).  A t-test of mean differences on all key independent and dependent variables 
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(outlined in Sections 5.3.1-5.3.4) was performed to establish that the two groups did not 
differ significantly.  None of these mean differences between groups were found to be 
significant at p ≤ 0.05.  Although a listwise deletion method of dropping the observations 
with missing values could be used for a small amount of missing data (<5%) and data found 
to be missing at random, we decided to use an imputation method which allowed us to keep 
all observations (n=139) in each multivariable analysis.  Missing values for any variable—
including continuous, discrete and categorical variables—were substituted with the mean 
value for that variable.  All substitutions were made prior to regression analyses and before 
any of the multi-item scales were created.
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5.4.3. Analysis by Aims 
Aim 1: To examine the relationship between the medication-related stressors 
experienced by the caregiver and caregiver depression. 
Caregiver emotional health—depression presence and severity—was the dependent 
variable used in this analysis.  Because the distribution of the depression scores was skewed 
to the right, this variable was transformed by taking the square root of the score.  A 
frequency plot verified that this transformed variable was normally distributed.  Therefore, 
the dependent variable for depression was the square root of the caregiver’s PHQ-9 
depression score and it was modeled as a continuous variable.  The independent variables 
that were modeled included the caregiver and care-recipient contextual factors, caregiver 
resources, and medication related stressors that were outlined in the conceptual model 
(Chapter 2) and measurement (Chapter 5) sections.   
All caregiver sociodemographic variables (age, gender, race, marital status, and 
education) were included in the model.  In addition, a bivariate analysis using t-tests was 
performed to determine the association between the emotional health outcome and the other 
independent variables which were measured under caregiver and care-recipient contextual 
factors (Section 5.3.1), medication-related stressors and caregiver resources.  Only 
independent variables that were statistically significant in the bivariate analysis were 
modeled in the multivariable analysis.  Both the caregiver sociodemographic variables and 
the significant variables from the bivariate analysis were added in stages during the 
multivariable analysis.  First, the caregiver and care-recipient contextual factors were added.  
In the second stage, the stressors were added.  Finally, the caregiver resources were added to 
the model.  Tolerance statistics were also calculated with the PROC GLM procedure in SAS 
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to measure the strength of the interrelationships between the independent variables.  In order 
to test the assumptions of the model, residuals were also calculated and examined for the 
model.  A histogram of the residual values was plotted to test for a normal distribution.  The 
residuals were also plotted against the predicted values to ensure that their distribution was 
scattered randomly around zero. 
A Sobel test was conducted to test for the size and significance of the indirect effect 
of social support as a mediator between the medication-related stressors and caregiver 
depression (Baron and Kenny, 1986).   This was done to test whether social support, the 
mediator, carries the influence of medication-related stressors (independent variables) to 
caregiver depression (dependent variable).  Two tests were conducted with medication 
administration and medication effects both tested as the independent variable.  The 
mediation, path coefficients (a, b and c) and standard errors of the path coefficients (sa and 
sb) are illustrated in Figure 5.1.  The test of the indirect effect was calculated using the 
formula, ab/√b2sa2 + a2sb2, and treating the ratio as a Z test.  The Z statistic was test at the 
0.05 significance level. 
 
Figure 5.1: Illustration of Mediator Model 
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Aim 2: To examine the association between the caregiver primary medication-related 
stressors and (a) the caregiver contextual factors and (b) the care-recipient contextual 
factors. 
The primary stressors were the factors identified in the SCMC scale validation and 
factor analysis.  Each domain—medication administration and medication effects—were 
measured using continuous variables and modeled with ordinary least square (OLS) 
regression.  A bivariate analysis using t-tests was performed to determine the association 
between the medication-related stressors and the caregiver and care-recipient contextual 
variables (except for the caregiver sociodemographics).  Then, both the caregiver 
sociodemographic variables and the significant variables from the bivariate analysis were 
modeled simultaneously in the multivariable analysis.  Tolerance statistics and residuals were 
measured as in Aim 1. 
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Aim 3:  To examine the association between the secondary medication-related stressors 
(e.g, time missed from work, social activities and family functions) of the caregiver and 
(a) the caregiver contextual factors and (b) the care-recipient contextual factors. 
Initially, caregiver secondary medication-related stressors were measured as three 
separate dependent variables—number of times missed work, number of times left work 
early/got to work late, and number of missed social activities.  Multivariable modeling to 
predict either missing work or leaving work early was designed to be run using only 
caregivers who reported being employed on either a part or full-time basis; however, only 53 
caregivers (39%) were employed at the time of the survey.  This resulted in too small of a 
sample size for a valid regression model that would have also required controlling for the 
level of employment (e.g., part-time versus full-time).  Therefore, this analysis was dropped 
from the study and will not be reported as originally planned.  The variable for number of 
times a caregiver missed social activities was analyzed and it was modeled as a continuous 
variable in this analysis.  Again, a bivariate analysis using t-tests was performed to determine 
the association between the number of missed social activities and the caregiver and care-
recipient contextual variables (except for the caregiver sociodemographics).  Then, both the 
caregiver sociodemographic variables and the significant variables from the bivariate 
analysis were modeled simultaneously in the multivariable analysis.  Tolerance statistics and 
residuals were measured as in Aims 1 and 2.  
 67
Aim 4: To describe caregivers attitudes about pharmacists and pharmacy services and 
determine what caregivers believe can be done to assist them with medication-related 
concerns. 
Both quantitative and qualitative analyses were performed for this Aim.  A 
descriptive analysis is presented to demonstrate the caregiver’s satisfaction with their current 
pharmacy care delivery system and whether or not they view pharmacists as a current and 
potential mechanism of support for medication-related concerns.  At the end of the 
questionnaire the caregivers were asked to, “Please use this space to share with us any other 
thoughts or ideas that you have about managing your loved one’s medications or about 
caregiving, in general.”  A qualitative analysis of these free-form comments (Appendix 4) 
that referred to pharmacists and pharmacy services is also incorporated. 
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CHAPTER SIX 
RESULTS 
 
6.1. Study Population 
 
6.1.1. Caregiver Demographics 
A total of 189 caregivers were recruited and provided with a study questionnaire for 
the research, Caregivers of Persons with Memory Problems: the Medication Study.  
Completed questionnaires were received for 139 caregivers for an overall response rate of 
74%.  The demographics of the participating caregivers are outlined in Table 6.1.  The 
responding caregivers were older adults with an average age of 61.4 years (SD=12.2) and a 
range from 29 to 87 years.  The majority of the caregivers were female, 102 (74.8%), and 
White, 113 (82.7%).  About 38% (n=53) reported to still be employed, either on a full or 
part-time basis.  Approximately 58% (n=80) of the caregivers reported an annual income of 
greater than $30,000.  The majority of the caregivers (79%) had received formal education 
beyond high school with 107 of the 139 caregivers having at least some level of college 
education.    
There was a wide range in the length of time the respondents reported having been a 
caregiver with a low of 0.25 years to a high of 20 years, with an average of 5 years (SD=3.5).  
The relationship of the caregiver to the care-recipient was well distributed with 66 (47.5%) 
being the spouse of the care-recipient, 49 (35.3%) being a child, and 21 (15.1%) reporting 
another relationship.  The majority of the caregivers (70.5%) currently resided in the same 
household as the care-recipient for whom they were responsible.  The average subjective 
social support score for the caregivers was 12.5 (SD=2.7) with a range of 3 to 18.  
Cronbach’s alpha for the subjective social support score was 0.73 which is within the range 
of 0.71-0.81 that has been reported in previous studies (Koenig 1993).  Perceived financial 
adequacy mean scores were 6.1 (SD=1.1) with a range of 3 to 8.  Both the support and 
perceived financial adequacy scores were near the middle of the possible range for these 
measures.   
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Table 6.1:  Caregiver Demographics (n=139) 
 
Age (years)  
Mean (SD) 61.42 (12.3) 
Range 29-87 
  
Gender—n (%)  
Male 32 (23) 
Female 104 (74.8) 
Missing 3 (2.2) 
  
Race—n (%)  
White 115 (82.7) 
Alaskan/American Indian 2 (1.4) 
Black/African American 19 (13.7) 
Hispanic/Latino 2 (1.4) 
  
Education—n (%)  
Less than high school 5 (3.6) 
High school diploma 24 (17.3) 
Some college 33 (23.7) 
College degree 37 (26.6) 
Graduate/professional degree 37 (26.6) 
Missing 3 (2.2) 
  
Employment Status—n (%)  
Working full-time 35 (25.2) 
Working part-time 18 (12.9) 
Retired 60 (43.2) 
Unemployed 9 (6.5) 
Disabled 6 (4.3) 
Other 8 (5.8) 
Missing 3 (2.2) 
  
Marital Status—n (%)  
Currently married 108 (78.4) 
Separated 1 (0.7) 
Divorced 9 (6.5) 
Widowed 6 (4.3) 
Never married 9 (6.5) 
Other 2 (1.4) 
Missing 3 (2.2) 
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Annual Income—n (%)  
Less than $9,000 7 (5) 
$9,001-$18,000 17 (12.2) 
$18,001-$30,000 28 (20.1) 
$30,001-$40,000 22 (15.8) 
$40,001-$50,000 14 (10.1) 
$50,001-$60,000 12 (8.6) 
Above $60,000 32 (23) 
Missing 7 (5) 
  
Length of Time as Caregiver (years) 
Mean (SD) 5.02 (3.5) 
Range 0.25-20 
  
Live with Care-recipient—n (%) 
Yes 98 (70.5) 
No 38 (27.3) 
Missing 3 (2.2) 
  
Relationship to Care-recipient—n (%) 
Spouse 66 (47.5) 
Child 49 (35.3) 
Other relative 18 (12.9) 
Other 3 (2.2) 
Missing 3 (2.2) 
  
Caregiver for others—n (%)  
Yes 30 (21.6) 
No 106 (76.2) 
Missing 3 (2.2) 
  
Subjective Social Support  
Mean (SD) 12.5 (2.7) 
Range 3-18 
  
Perceived Financial Adequacy  
Mean (SD) 6.1 (1.1) 
Range 3-8 
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6.1.2. Caregiver Emotional Health Outcome   
Emotional health outcomes for the caregivers are presented in Table 6.2.  The 
majority of caregivers in the study population reported low levels of depression presence and 
severity with 70.5% (n=98) having none to mild depression with PHQ-9 scores between 0 
and 9.  Forty-one caregivers (29.5%) did report moderate to severe depression with PHQ-9 
scores of 10 or greater.  The average PHQ-9 score among all caregivers was 7.00 (SD 5.34) 
and a range of 0-26 and presented a distribution curve that was skewed to the right.  
Cronbach’s alpha in this population of caregivers was 0.88 which was consistent with the 
range (0.86 to 0.89) that has previously been reported in studies within a variety of practice 
settings (Spitzer, 1999; Spitzer, 2000).     
 
Table 6.2:  Caregiver Reported Emotional Health (n=139) 
Depression (PHQ-9)  
Mean (SD) 7.00 (5.34) 
Range 0-26 
  
Depression (PHQ-9) Categories—n (%)  
None to mild (score 0-9) 98 (70.5) 
Moderate to severe (score 10-27) 41 (29.5) 
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6.1.3. Medication-related Stressors 
The summary of the findings of medication-related stressors can be found in Table 
6.3.  Both primary medication stressors—medication administration and medication effects 
were normally distributed average scores near the middle of the scoring range.  The average 
medication administration burden was 15.1 (SD 5.9) with a range of 0-29.  Medication effect 
burden scores averaged 9.7 (SD 3.9) with a range of 0-20.  There were a significant number 
of caregivers, however, who responded to having missed social or family activities to handle 
medication problems.  Over 38% (n=51) of the caregivers responded ‘yes’ to this item.  Of 
those respondents who had missed social or family activities, they reported that it had 
occurred on average 3.1 times (SD 2.4, range 1-14) within the past 30 days.   
As mentioned in the caregiver characteristics, there were only 53 caregivers who 
reported being employed on either a full or part-time basis.  Of those caregivers who were 
employed, only 13 (24.5%) caregivers responded that they had missed an entire day of work 
while 20 (37.7%) said that they had been forced to leave work early.  For those caregivers 
who did respond ‘yes’ to these items, the average number of times that the caregiver reported 
missing an entire day of work within the past 30 days was 3.9 (SD 6.1, range 1-20) and 
leaving work early within the past 30 days was 2.7 (SD 3.0, range 1-10).  Table 6.3 shows 
the number of caregivers who missed or left work early as a percentage of the caregivers who 
were employed (n=53).  Due to the small number of caregivers who were employed, no 
further analysis was performed on work-related variables/responses. 
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Table 6.3:  Summary of Medication-related Stressors 
 
Primary Medication-related stressors 
Medication Administration (n=139) 
Mean (SD) 15.1 (5.9) 
Range 0-29 
  
Medication Effects (n=139)  
Mean (SD) 9.7 (3.9) 
Range 0-20 
  
Secondary Medication-related stressors 
  
Missed Social/Family Activities—n (%) (n=139) 
Yes 53 (38.1) 
No 82 (59) 
Missing 4 (2.9) 
  
If ‘Yes’, number of times  
Mean (SD) 3.1 (2.4) 
Range 1-14 
 
Missed Work—n (%)—of those who were 
employed (n=53) 
Yes 13 (25.5) 
No 40 (74.5) 
  
If ‘Yes’, number of times  
Mean (SD) 3.9 (6.1) 
Range 1-20 
  
Left Work Early—n (%)  
Yes 20 (37.7) 
No 33 (62.3) 
  
If ‘Yes’, number of times  
Mean (SD) 2.7 (3.0) 
Range 1-10 
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6.1.4 Care-recipient Medication Management 
Caregivers reported managing 6.5 prescription medications (SD=3.7, range 0-21).  
The majority of the care-recipients, over 87%, were covered by a prescription drug plan with 
over half being covered by a private insurance plan (n=51) or a Medicare Part D plan (n=37).  
The remaining caregivers were covered by either Medicaid (n=20), the Veterans 
Administration (n=12), or an ‘Other’ plan (n=3).  Caregivers used 1.4 pharmacies (SD=0.61, 
range 1-4), on average.  The caregivers listed the pharmacies that were used and each of them 
was categorized into one of three categories—chain, independent, or mail-order pharmacy.  
Chain pharmacies were the most frequent type of pharmacy used for obtaining medications 
with 87 caregivers reporting their use.  Independent and mail-order pharmacies were used by 
45 and 44 caregivers, respectively.  These findings are summarized in Table 6.4. 
  
Table 6.4:  Summary of Medication Management (n=139) 
 
Number of medications  
Mean (SD) 6.5 (3.7) 
Range 0-21 
  
Prescription Drug Insurance—n (%) 
Yes 121 (87.1) 
No 16 (11.5) 
Missing 2 (1.4) 
  
Type of Prescription Drug Insurance—n (%) 
Private Insurance 51 (36.7) 
Medicaid 20 (14.4) 
VA 12 (8.6) 
Medicare 37 (26.6) 
Other 3 (2.2) 
  
Number of Pharmacies Used 
Mean (SD) 1.4 (0.61) 
Range 1-4 
  
Types of Pharmacies Used—n (%) 
Chain Pharmacy 87 (62.6) 
Independent Pharmacy 45 (32.4) 
Mail Order Pharmacy 44 (31.7) 
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6.1.5. Care-recipient Demographics 
The care-recipients were older adults with an average age of 79.5 years (SD=8.9) 
with a range of 55 to 95 years old.  The distribution of males to females was relatively equal 
with 46.8% and 51.8%, respectively.  As was the case with the caregivers, the care-recipients 
were primarily White (84.2%).  Of the non-White care-recipients, 10.1% were Black.  The 
level of formal education among the care-recipients was well-distributed with 48.2% having 
a high school diploma or less and the remainder having some college education.  The 
majority (n=76) were still married and living with their spouse or partner (n=69).  While the 
caregivers reported a range of zero to 13 living children for the care-recipients, the average 
number was 2.9 children (SD=1.9) and the distribution of the responses were skewed to the 
right.  As was expected with the elderly care-recipient population, the average number of 
medical comorbidities using the OARS instrument was 4.7 (SD=2.6) with a range of 1 to 15.  
The majority of the care-recipients were also highly reliant on their caregivers for assistance 
with IADLS based on the average score of 17.1 (SD=3.2) and range of 8 to 21 with a 
distribution of scores that was skewed to the right.  These findings are outlined in Table 6.5. 
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Table 6.5:  Care-recipient Demographics (n=139) 
Age (years)  
Mean (SD) 79.5 (8.9) 
Range 55-95 
  
Gender—n (%)  
Male 65 (46.8) 
Female 72 (51.8) 
Missing 2 (1.4) 
  
Race—n (%)  
White 117 (84.2) 
American Indian/Alaskan 3 (2.2) 
Black/African American 14 (10.1) 
Hispanic/Latino 2 (1.4) 
Other 1 (0.7) 
Missing 2 (1.4) 
  
Education—n (%)  
Less than high school 32 (23) 
High school diploma 35 (25.2) 
Some college 31 (22.3) 
College Degree 22 (15.8) 
Graduate/Professional degree 17 (12.2) 
Missing  2 (1.4) 
  
Marital Status—n (%)  
Currently married 76 (54.7) 
Separated 1 (0.7) 
Divorced 8 (5.8) 
Widowed 50 (36) 
Never married 2 (1.4) 
Missing 2 (1.5) 
  
Number of Children  
Mean (SD) 2.9 (1.9) 
Range 0-13 
  
Living Arrangements—n (%) 
Spouse/partner 69 (49.6) 
Other relatives 40 (28.8) 
Unrelated individuals 17 (12.2) 
Alone 10 (7.2) 
Missing 3 (2.2) 
  
Number of Comorbidities (OARS) 
Mean (SD) 4.7 (2.6) 
Range 1-15 
  
IADL Functional Status (OARS)  
Mean (SD) 17.1 (3.2) 
Range 8-21 
 
 
 78
6.2  Bivariate Analysis and Correlations 
 
Bivariate analyses were performed for each dependent variable included in Aims 1-3 
and the independent variables of interest—caregiver/care-recipient contextual factors, 
stressors and caregiver resources.  Only significant bivariate relationships were included in 
the multivariable models with the exception of caregiver sociodemographics (age, gender, 
race, marital status, education) which were included in each model as control variables.  
Table 6.6 details the bivariate relationships between the dependent and independent 
variables.  A correlation matrix was also run to examine the relationships between the 
independent variables.  These findings are in Table 6.7. 
 
Contextual to Contextual (Caregiver and Care-recipient):  Caregiver age was 
positively correlated with being male (r=0.2708, p=0.0015), being married (r=0.2877, 
p=0.0007), having no more than a high school education (r=-0.2070, p=0.0160), being the 
primary caregiver for another person (r=0.3438, p=<0.0001), reporting a longer period of 
time as a primary caregiver (r=0.2684, p=0.0016) and caring for a loved one with fewer 
medical comorbidities (r=-0.2019, p=0.0188).  Caregivers were more likely to be caring for a 
loved one of the opposite sex (r=-0.2799, p=0.0010) while male caregivers were more likely 
to be caring for a loved one with more medical comorbidities.  White caregivers were more 
likely to have been a primary caregiver for a longer period of time (r=0.1758, p= 0.0414).  
Being a married caregiver was positively correlated with being a primary caregiver for 
another loved one (r=.1798, p=0.0362) and negatively correlated with their care-recipient’s 
age (r=-0.2364, p=0.0058).  Caregivers with formal education beyond a high school diploma 
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were more likely to be employed (r=0.2401, p=0.0044).  Caregivers who were primary 
informal caregivers for another loved one were more likely to be caring for a male loved one 
with memory problems (r=0.2529, p=0.0030).  The length of time that the caregiver has been 
caring for their loved one was positively correlated with higher functional impairment 
(r=0.2955, p=0.0005).  Male care-recipients were more likely to be younger (r=-0.2794, 
p=0.0010).  Care-recipient age was positively correlated with poor functional status 
(r=0.2406, p=0.0049) and negatively correlated with the number of medications that they 
were taking (r=-0.2056, p=0.0163).  Male care-recipients were more likely to have less 
functional impairment (r=-0.2157, p=0.0117).  Greater functional impairment was positively 
correlated with the number of their medical comorbidities (r=0.1903, p=0.0265).  The 
number of medical comorbidities of the care-recipient was positively correlated with the 
number of medications that they were taking (r=0.4765, p<0.0001).  Those caregivers who 
reported spending less time on caregiving activities were more likely to have formal 
education beyond high school (r=-0.2421, p=0.00614) and be employed (r=-0.2683, 
p=0.0023) while time spent on caregiving activities was positively correlated with care-
recipient functional impairment (r=0.4248, p=<0.0001). 
 
Contextual to Caregiver Resources:  The age of the caregiver was negatively 
correlated with their self-reported physical health (r=-0.3040, p=0.0004) but positively 
correlated with their satisfaction with their pharmacy services (r=0.3018, p=0.0004).  White 
caregivers reported better physical health (r=0.2383, p=0.0055).  Caregivers who were 
married were more likely to report higher scores for perceived financial adequacy (r=0.2167, 
p=0.0116).  Caregivers with formal education beyond high school were more likely to report 
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better physical health (r=0.2397, p=0.0053).  The amount of time spent on caregiving 
activities was negatively correlated with caregiver physical health (r=-0.2038, p=0.0232) and 
perceived financial adequacy (r=-0.2475, p=0.0052).  The age of the care-recipient was 
positively correlated with both caregiver social support (r=0.2055, p=0.0168) and 
satisfaction with pharmacy services (r=0.1716, p=0.0491).  Poor functional status of the 
care-recipient was negatively correlated with caregiver social support (r=-0.1783, p=0.0386), 
caregiver physical health (r=-0.2210, p=0.0106) and perceived financial adequacy (r=-
0.2144, p=0.0128).  The number of care-recipient medical comorbidities was negatively 
correlated with caregiver social support (r=-0.1797, p=0.0386) and caregiver physical health 
(r=-0.2604, p=0.0024).  Finally, the number of care-recipient medications was negatively 
correlated with caregiver social support (r=-0.2662, p=0.0017), perceived financial adequacy 
(r=-0.1798, p=0.0369) and satisfaction with pharmacy services (r=-0.1894, p=0.0290) 
 
Contextual to Medication-related Stressors:  The time spent on caregiving activities 
was positively correlated with caregiver concerns about medication administration 
(r=0.2508, p=0.0048).  The level of care-recipient functional impairment was positively 
correlated with caregiver concerns with medication effects (r=0.2616, p=0.0022).  The 
number of care-recipient medical comorbidities was positively correlated with caregiver 
concerns with both medication administration (r=0.2328, p=0.0070) and effects (r=0.2414, 
p=0.0122).  Finally, the number of care-recipient medications was positively association with 
medication administration concerns (r=0.2377, p=0.0059). 
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Caregiver Resources to Caregiver Resources:  Caregiver social support was 
positively correlated with all other caregiver resources:  physical health (r=0.3440, 
p=<0.0001), perceived financial adequacy (r=0.2842, p=0.0008) and satisfaction with 
pharmacy services (r=0.2453, p=0.0044).  In addition to social support, caregiver physical 
health was positively correlated with perceived financial adequacy (r=0.3256, p=0.0001). 
 
Caregiver Resources to Medication-related Stressors:  Caregiver social support was 
negatively correlated with both medication administration (r=-0.3018, p=0.0004) and effects 
(r=-0.2811, p=0.0009).  Caregiver physical health was negatively correlated with medication 
effects (r=-0.1831, p=0.0342) and the number of social activities missed by the caregiver 
(r=-0.2326, p=0.0068).  Caregiver perceived financial adequacy was negatively correlated 
with all three medication-related stressors: administration (r=-0.1816, p=0.0371), effects 
(r=-0.1808, p=0.0359) and number of missed social activities (r=-0.1885, p=0.0285).  
Satisfaction with pharmacy services was only correlated (negatively) to medication effects 
(r=-0.2781, p=0.0012). 
 
Medication-related Stressors to Medication-related Stressors:  Caregiver concerns 
with medication administration was positively correlated with their concerns about 
medication effects (r=0.4871, p=<0.0001). 
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6.3. Analysis by Aims 
 
Each stage of every multivariable model was tested by (1) running tolerance statistics to test 
the interrelationships between explanatory variables and (2) calculating residuals and 
predicted values for each of the models and plotting them against one another to ensure that 
the distribution was scattered randomly around zero.  The tolerance statistics for the variables 
in each model were all above 0.55; so, there was no concern of collinearity between the 
independent explanatory variables in the models.  The frequency plot of residuals for each 
model confirmed a normal distribution.  The plot of residual values against the predicted 
values also confirmed that the assumptions of the models were met as the distribution of the 
points was scattered randomly around 0.
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6.3.1. Aim 1: To examine the relationship between the medication-related stressors 
experienced by the caregiver and caregiver depression. 
 
Multivariable analysis results are shown in Table 6.8.  The multivariable analysis of 
caregiver emotional health is presented in the stages outlined in the Methods (Chapter 5).  
First, all caregiver sociodemographic variables along with caregiver and care-recipient 
contextual variables that were significant in the bivariate analysis were added.  This was 
followed by caregiver stressors and caregiver resources added in Stage 2 and Stage 3, 
respectively.  In the last two stages, only variables with significant bivariate relationships 
(Table 6.3) were added.  In Stage 1, care-recipient age was the only variable that remained 
significant in the multivariable model (p=0.0098).  Care-recipient age and caregiver 
depression were negatively associated with caregivers who were caring for younger loved 
ones reporting higher levels of depression.  After adding medication-related stressors, both 
care-recipient age (p=0.0441) and medication effects (p=0.0044) were significant.  As in 
Stage 1, care-recipient age remained negatively associated with depression.  However, 
medication effects were positively associated with the emotional health of caregivers.   
In the final stage of the model (Stage 3) which added the caregiver resources, 
caregiver depression was associated with only subjective social support and medication 
effects and was no longer associated with care-recipient age.  Caregivers who reported 
having more difficulty handling the medication effects reported higher depression scores 
(p=0.0480).  Subjective social support was also associated with depression among this group 
of caregivers.  Caregivers with less subjective social support also reported higher depression 
scores (p<0.0001) than caregivers who reported feeling more supported.   
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We notice that the path from the medication-related stressors to the emotional health 
outcome measure—caregiver depression—becomes either less significant (medication 
effects) or insignificant (medication administration) when social support is added to the 
model.  Thus, when adding subjective social support as a predictor variable, it carries the 
weight of the regression model and mediates the pathway between the stressors and the 
emotional health outcome.  This finding supports the conceptual framework outlined in 
Chapter 2.  Care-recipient age became statistically insignificant when social support was 
added to the regression model in Stage 3.  This occurred because care-recipient age 
(p=0.0166) and subjective social support (p<0.0001) are positively related to the dependent 
variable—caregiver depression—and they are positively related to one another.  So, once the 
model is controlled for social support, the association between care-recipient age becomes 
less significant. 
The Sobel test results demonstrated statistically significant indirect effects with social 
support as a mediator between both medication-related stressors and caregiver depression.  
The Sobel test statistic for medication administration was 3.61598 with p=0.0030 while the 
test statistic for medication effects was 3.46341 with p=0.00053.  This supports the original 
hypothesis that the relationship between the medication-related stressors and caregiver 
depression is mediated by caregiver subjective social support. 
There were two findings in this regression modeling that were not consistent with the 
original hypotheses.  There was no association between the medication administration 
stressor or the secondary medication-related stressor—number of times missed social/family 
activities.  Although there was a bivariate relationship, there was no statistically significant 
association between depression and medication administration—after controlling for 
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caregiver and care recipient contextual factors and caregiver resources.  The number of times 
a caregiver missed social/family activities was not significant in the bivariate analysis 
(p=0.2258) and, thus, was not included in any of the stages of the multivariable modeling.  
As additional variables were modeled in stages, the R-squared increased from 0.1738 in 
Stage 1 to 0.2621 in Stage 2 to 0.4489 in Stage 3.  So, within the final stage of modeling, 
nearly 45% of the variation in caregiver depression is explained by the independent variables 
included in the model.
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6.3.2. Aim 2: To examine the association between the caregiver primary medication-
related stressors and (a) the caregiver contextual factors and (b) the care-recipient 
contextual factors. 
  
 The multivariable findings are outlined in Table 6.9 and 6.10.  After multivariable 
modeling of caregiver and care-recipient contextual factors against both domains of primary 
medication-related stressors—administration and effects—some associations were identified.  
Caregiver race were the only statistically significant predictor for medication administration.  
More problems with medication administration were reported by caregivers who were White 
(p=0.0255).  For the medication effects domain, both care-recipient predictor variables—
care-recipient IADL functional status (p=0.0134) and the number of care-recipient 
comorbidities (p=0.0343)—that were significant in bivariate analysis remained significant in 
the multivariable model.  These were both positive associations with the higher the IADL 
score (greater functional impairment) and the more care-recipient comorbidities, the higher 
the stressor scores for medication effects.  None of the caregiver sociodemographics were 
associated with the medication effects stressor in either the bivariate or multivariable model.  
Nearly 15% of the variation in medication administration was explained by the regression 
model (R-squared=0.1490) while about 12.5% of the variation in medication effects was 
explained the model (R-squared=0.1256).
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Table 6.9: Multivariable Analysis of Medication Administration with Caregiver and Care-
recipient factors 
 
MEDICATION ADMINISTRATION (N=139)  
Characteristic STAGE ONE Model Contextual Factors 
 Only 
 b p 
Caregiver Contextual Factors   
 Age -0.00430 0.9344 
Gender (male=1;female=0) -0.41683 0.7652 
Race (1=white;0=non-white) 3.37646 0.0255 
Marital Status (1=married;0=not married) -0.21969 0.8827 
Education (1=≥HS graduate;0=<HS grad) -0.32535 0.3369 
   
Care-recipient Contextual Factors   
Number of comorbidities 0.41567 0.0964 
Number of medications 0.30275 0.0846 
   
R-squared  0.1490 
  
 
Statistically significant variables are in BOLD. 
 
 
 
 
Table 6.10: Multivariable Analysis of Medication Effects with Caregiver and Care-recipient 
factors 
 
MEDICATION EFFECTS (N=139)  
Characteristic STAGE ONE Model Contextual Factors 
 Only 
 b p 
Caregiver Contextual Factors   
 Age 0.02189 0.4641 
Gender (male=1;female=0) 0.80804 0.3126 
Race (1=white;0=non-white) 1.09074 0.2012 
Marital Status (1=married;0=not married) -0.89467 0.2893 
Education (1=≥HS graduate;0=<HS grad) 0.62038 0.4256 
   
Care-recipient Contextual Factors   
Functional status 0.25789 0.0134 
Number of comorbidities 0.27190 0.0343 
   
R-squared  0.1256 
  
 
Statistically significant variables are in BOLD. 
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 6.3.3. Aim 3:  To examine the association between the secondary medication-related 
stressors (e.g., time missed from work, social activities and family functions) of the 
caregiver and (a) the caregiver contextual factors and (b) the care-recipient contextual 
factors. 
 
The multivariable findings are outlined in Table 6.11.  There were three variables 
associated with the number of missed social activities—caregiver age (p=0.0255), caregiver 
education (p=0.0201), and the number of care-recipient comorbidities (p=0.0195).  Older 
caregivers and caregivers with a high school education or greater missed more social 
activities.  Caregivers with less than a high school education missed an average of 0.59 
(adjusted mean) social activities compared to caregivers with at least a high school education 
who missed 1.14 (adjusted mean) social activities, on average.  Caregivers who reported 
caring for a loved one with a higher number of comorbidities missed more social activities 
than those who reported fewer comorbidities.  About 10% of the variation in the number of 
missed social activities was explained by this regression model (R-squared=0.1023).  As 
discussed in Chapter 5, the number of caregivers who worked was too small of a sample size 
(n=53) for a valid regression model that would have also required controlling for the level of 
employment (e.g., part-time versus full-time).  Therefore, this analysis was dropped from the 
study and not reported.  
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Table 6.11:  Multivariable Analysis of Social-related Stressor with Caregiver and Care-
recipient Factors (n=129) 
 
SOCIAL MISS TIMES (N=139)  
Characteristic STAGE ONE Model Contextual Factors 
 Only 
 b P 
Caregiver Contextual Factors   
 Age 0.03545 0.0225 
Gender (male=1;female=0) 0.10076 0.8059 
Race (1=white;0=non-white) -0.76952 0.0822 
Marital Status (1=married;0=not married) -0.30832 0.4798 
Education (1=≥HS graduate;0=<HS grad) 0.85752 0.0344 
   
Care-recipient Contextual Factors   
Number of comorbidities 0.15253 0.0195 
   
R-squared  0.1023 
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6.3.4. Aim 4: To describe caregivers attitudes about pharmacists and pharmacy services 
and determine what caregivers believe can be done to assist them with medication-
related concerns. 
 There were both quantitative and qualitative findings for this Aim.  First, I will 
discuss the quantitative results from the Pharmacy Support Scale which covered the 
caregiver’s perception of the availability of and communication and interaction with the 
pharmacist.  Next, I will present the qualitative results which are from the free-form 
comments that were included by the caregivers at the end of the study questionnaire.  At the 
end of the questionnaire the caregivers were asked to, “Please use this space to share with us 
any other thoughts or ideas that you have about managing your loved one’s medications or 
about caregiving, in general.”  The comments that were specifically related to medication 
management or their thoughts about pharmacists/pharmacy services were categorized and 
presented below under Qualitative Findings. 
  
Quantitative Findings:  The distribution of responses to the questions about 
caregiver’s perceptions of pharmacists and pharmacy services are in Table 6.12 while the 
descriptive statistics for these items are presented in Table 6.13.  The most favorable 
responses regarding pharmacists was both their availability and ability to answer questions 
about medications with caregivers, 79.5% and 81.3%, respectively, responding that they 
agreed or strongly agreed with those statements.  Items that related to the pharmacist being 
proactive in their communication were not viewed as positively by caregivers with ‘agree’ or 
‘strongly agree’ responses from 51.5% (n=69) regarding the pharmacist warning them about 
problems, 48.8% (n=65) regarding the pharmacist telling them what the medication is used 
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for, and 49.3% (n=66) regarding the pharmacist giving advice that helps the caregiver to 
manage the loved one’s medications.  Sixty-six caregivers (49.3%) responded favorably 
(agree/strongly agree) to the pharmacist caring about their overall health and well-being 
while 89 caregivers (66.4%) did trust the pharmacist to give them the best information about 
medications.   
The lowest responses from caregivers about pharmacy services were related to the 
privacy at their local pharmacy, the time spent by the pharmacist and their perception that the 
pharmacist worked closely with their loved one’s doctor.   Only 45 caregivers (33.6%) 
believed that that there was a place at the pharmacy where they could talk in private with 
their pharmacist and just 68 caregivers (51%) were satisfied with the amount of time spent by 
the pharmacist.  Finally, only 51 caregivers (38.1%) felt as if their pharmacist worked with 
their loved one’s doctors to provide the best medications possible.   
Qualitative Findings:  The free form comments related to medication management 
included by caregivers at the end of the study questionnaire were collated and grouped into 
five categories:  (1) support for medication management, (2) organizing medications, (3) 
affording medications, (4) scheduling medication fills/refills, and (5) pharmacist/pharmacy 
experiences.  A summary of the qualitative findings are in Table 6.14.  There were many 
other comments that were related to the overall burden and stress of caregiving; however, 
those were not categorized as that was outside the scope of this research study.  The majority 
of the comments related to medication management that were included by caregivers were 
consistent with the questions that were included in the SCMC scale and its two domains—
medication administration and medication effects.  The comments under organizing 
medications, affording medications and scheduling medication fills/refills were all included 
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in the medication administration items while the majority of the comments under 
pharmacist/pharmacy experiences were included in the medication effects items.  However, 
there were two comments under pharmacist/pharmacy experiences that were not addressed in 
the SCMC and those were issues around mail order pharmacy delays and the difficulties 
associated with prescription bottles (e.g., problems with bottle caps and small print).  One 
other issue raised in the comments that was not addressed in the study questionnaire was 
level of support available to the caregiver from family, friends or others specifically for 
medication management.  The two handwritten comments referred to having either hired help 
(e.g., home health aide) or a family member (e.g., sister) help administer or organize the 
medications.  The concept of substitution and the availability of others to help with the 
process and its subsequent impact on the medication management process were captured in 
the qualitative analysis but not in the quantitative one.
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Table 6.13: Descriptive Statistics for Satisfaction with Pharmacist and Pharmacy Services 
(n=139) 
 
    
 Mean SD Range 
The pharmacist is usually available to answer 
my questions about my loved one’s 
medications. 
2.96 0.96 0-4 
    
The pharmacist warns me about problems that 
my loved one might have with the 
medications. 
2.29 1.21 0-4 
    
The pharmacist tells me what my loved one’s 
medications are used for. 2.17 1.22 0-4 
    
I receive advice from the pharmacist that helps 
me to manage my loved one’s medications. 2.21 1.17 0-4 
    
The pharmacist answers any questions that I 
have about my loved one’s medications. 2.88 0.96 0-4 
    
I feel like the pharmacist really cares about my 
overall health and well-being. 2.37 1.14 0-4 
    
There is a place at the pharmacy where I can 
talk in private with the pharmacist. 1.81 1.22 0-4 
    
I am satisfied with the amount of time that the 
pharmacist spends with me. 2.37 1.07 0-4 
    
I trust the pharmacist to give me the best 
information about my loved one’s 
medications. 
2.67 1.05 0-4 
    
The pharmacist works with my loved one’s 
doctors to provide the best medications 
possible. 
2.10 1.05 0-4 
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Chapter 7 
DISCUSSION 
 
 This dissertation research produced four major findings:  (1) as hypothesized, there 
was an association between the medication-related stressors of dementia caregivers and their 
own emotional health,  (2) the presence of depression among these dementia caregivers and 
the association with social support were consistent with the previous literature that has 
reported poor emotional health outcomes in this population,  (3)  a reliable instrument, the 
Survey of Caregiver Medication Concerns, for measuring medication-related stressors was 
developed, and (4) caregivers’ reported perceptions of pharmacists and pharmacy services 
suggest that there are opportunities for pharmacists to improve their communication, 
education and practice environments. 
7.1. Medication-related Stressors 
 
As hypothesized, there was some association between caregiver emotional health and 
the medication-related stressors of the dementia caregivers.  The caregiver’s stress related to 
the effects and effectiveness of medications was associated with higher levels of depression 
presence and severity.  There was no association, however, between the other primary 
medication-related stressor—medication administration—and caregiver emotional health.  
One possible explanation for these findings is that the medication effects are not as clearly 
defined from a task perspective and require mastering communication skills and interpreting 
both verbal and non-verbal responses from their care-recipients.  The five items included in 
the medication effects domain of the primary medication-related stressors were related to 
how well the medications are or are not working and how the caregiver communicates with 
the care-recipient.  This can be challenging for caregivers and could negatively impact their 
own emotional health.   
On the other hand, the items included in the medication administration stressor are 
related to the task of obtaining and giving the medications.  Over time, caregivers develop 
strategies to manage the many tasks of caregiving by developing routines and this likely 
carries over to handling the tasks of managing medications.  By developing these systems to 
handle the tasks of caregiving, the disruptions for the care-recipient are minimized and this 
likely alleviates some of the caregiver burden, as well.   
Another possible explanation for the association between the medication effects is 
that the items within this domain also carry an emotional tone and ask more about caregiver’s 
“feelings.”  Therefore, these questions may be tapping into the caregiver’s anxiety or 
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depression and it may be unclear whether the medication-related stressor is causing the poor 
emotional health outcomes or if the poor emotional health is contributing to the negative 
feelings related to the medication-related concerns. 
In addition to the association of medication effects and caregiver emotional health, 
there was also a statistically significant association between caregiver subjective social 
support and depression.  Caregivers with lower levels of support were more depressed.  
While this is an important finding for this study as it did demonstrate a mediating effect 
between the medication-related stressors and the emotional health outcome, it is also 
consistent with other studies of the role of social support in caregiver depression.  These 
findings continue to highlight the importance of dementia caregiver support.  Caregivers can 
feel as if they must care for their loved one twenty-four hours a day, seven days a week; 
however, it is important for the caregiver to understand their co-existence with the demented 
patient and to have outlets and assistance with friends and family. 
 The one secondary medication-related stressor—missing social activities to handle 
medication problems—that was analyzed was not found to be associated with poorer 
caregiver emotional health.  Those caregivers who missed more social activities for 
medication-related issues did not report being more depressed than those who missed fewer 
social activities.  There are possible shortcomings in these items within this specific group of 
caregivers and the study questionnaire.  The recall period might have been too short.  
Caregivers were asked to recall within the past 30 days whether they had one of these 
occurrences.  It is likely that the event might have occurred at some point within the past few 
months to a year but not specifically within the past 30 days.  So, lengthening the recall 
period would likely have increased the responses for these questions.  It remains important to 
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understand how managing medications impacts work and social activities because keeping 
the caregiver active in employment and social/family support systems is important.  
However, work needs to be done to improve the method for assessing this problem.  Based 
on the results from this research study, we do know from a descriptive perspective that 
caregivers are being forced to miss time from work and other activities to deal with 
medication problems.  Because we were unable to model this as we originally planned, it still 
remains unclear if absence from work has a negative impact on caregiver emotional health.  
 There were also some associations between caregiver and care-recipient contextual 
factors and the medication-related stressors that should be noted.  Caregivers’ concerns with 
medication effects were associated with the care-recipient’s functional status and the number 
of comorbid conditions.  As hypothesized, a caregiver caring for a loved one who is more 
dependent on their caregiver and has multiple conditions will have more concerns about the 
effects and effectiveness of the medications being given to the care-recipient.  A demented 
person with poor functional status has more compromised cognition than those with higher 
levels of functioning.  Therefore, they are less likely to be able to communicate effectively 
with their caregiver about their medications and how they are either working or causing them 
problems.  A care-recipient with more comorbid conditions is more likely to be taking more 
medications that those with fewer comorbidities.  In this study population, there was a 
statistically significant correlation between the number of medications and the number or 
care-recipient comorbidities (p<0.0001).  Older adults who take several medications at one 
time are at risk for drug-related problems (Lim 1999).  These problems can be a result of 
either adverse drug reactions due to the way drugs act differently in compromised elderly 
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(e.g., renal disease, liver disease) or due to drug-drug interactions from the concomitant use 
of medications. 
 When examining predictors of missing social activities because of medication-related 
stressors, caregivers who were older and more educated and those who were caring for a 
loved one with more medical comorbidities missed more social activities.  Older caregivers 
in this study were probably less likely to be as active as their younger counterparts.  
Caregivers who were caring for a loved one with more medical comorbidities were likely to 
be dealing with a more complex situation than other caregivers and there may have been 
other contributors in their decision to miss social/family activities. 
The major conclusion related to medication-related stressors from this research is that 
we have learned that there is an association between some of the medication-related stressors 
and self-reported depression measure of caregiver emotional health.  These findings provide 
some support of the modified conceptual model and the Stress Process Model (Pearlin et al, 
1981) which suggests that caregiver stressors are directly linked to their emotional health 
outcome and that the process is mediated by the subjective social support of the caregiver. 
The associations between the caregiver emotional health outcomes and the 
medication-related stressors outlined in this research should continue to be evaluated.  Future 
research should be done to refine the medication-related stressors that were identified in this 
research.  This can be initiated by taking the SCMC instrument and qualitative findings from 
this research study and using in other dementia caregiver studies.  Further investigation of the 
support available for the medication management process is also needed.  Future studies 
should ask questions related to the availability and quality of friends/family who can be 
substitutes for medication management.  If we continue to use and refine this model, we will 
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be able to better understand the role of medication management in the overall stress process 
of dementia caregivers. 
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7.2. Emotional Health Outcomes of Caregivers 
 
We were also able to identify the presence of depression among this group of 
dementia caregivers which has been reported in other research. While the mean PHQ-9 score 
was in the mild depression category, 41 caregivers, approximately 30%, reported having 
moderate to severe depression.  This finding was consistent with recent studies by Schulz and 
Martire (2004) that documented 30 to 55% of caregivers reporting depressive 
symptomatology and Sleath et al (2005) showing that 30% of informal caregivers of 
demented relatives demonstrating depressive symptoms.  The presence and severity of 
depression may actually be higher in other caregiver settings where the majority of the 
caregivers are not recruited from a support group setting.  By being involved in support 
groups, the caregivers in this study have at least one outlet and mechanism for managing the 
burden of the caregiver process.  This likely has a certain level of positive impact on the 
caregiver’s emotional health.   
This research adds to the large body of existing literature that has documented the 
effect of caregiving on the emotional well-being of informal caregivers (Zarit et al, 1996; 
Schulz and Beach, 1999; Wilcox and King, 1999; Sleath et al, 2005).  These findings, along 
with ongoing research of caregiver emotional health, will allow us to continue to focus on the 
both the personal and emotional impact of dementia on families and caregivers. 
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7.3. Development of the Survey of Caregiver Medication Concerns Scale 
 
An important underlying objective of this research was to create a reliable measure of 
the impact of medication management on dementia caregivers and that was accomplished.  
Prior to the development of this instrument, there was no standardized method for measuring 
specific medication-related stressors of caregivers.  Other researchers have measured 
medication stressors of caregivers but a reliable instrument has not been developed and 
published to date (Ranelli, 1994; Smith, 2003).  Analysis of medication tasks could be done 
by examining the time burden as time spent on the activity of managing medications with a 
Caregiver Activity Survey; however, this method has limitations and does not address the 
many facets of medication management.   
 Through this study we were able to take qualitative responses obtained from 
caregivers in focus groups and transfer that information into specific questions for a study 
questionnaire.  Although item reduction analysis trimmed our available items for factor 
analysis from 21 to 15, there were two very distinct domains—medication administration and 
medication effects—that emerged from the factor analysis.  The factor structure was simple 
with items loading on one of two specific constructs.  The factors that were identified were 
also consistent with the primary areas of concern that were identified in the focus groups and 
literature review (Ranelli, 1994; Smith, 2003).  The Cronbach’s α coefficient for each of the 
domains was above the acceptable value of 0.70 which showed a good measure of internal 
consistency reliability. 
Five of the eight items that were excluded in the item-reduction analysis were related 
to the cost of prescription medications.  The majority of the qualitative research and original 
item development was done six to nine months prior to the implementation of Medicare Part 
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D.  There was no way to anticipate the impact that the new prescription drug coverage would 
have on the elderly population, including those with memory problems.  However, based on 
the caregiver responses from this study, the burden of prescription drug costs was lessened 
with Part D and was not a major concern of caregivers.  Caregiver perceptions of cost may 
have also been different with continued research later in the calendar year of 2006, as well, as 
Medicare Part D recipients hit the “doughnut hole” in their coverage.  This was also a 
population where nearly 37% of the care-recipients were covered by private insurance.  So, 
this provides further support that, at least in this population, the cost of prescription 
medications was less of concern than we had originally thought. 
The major accomplishment from this portion of the research is that a validated scale 
was created to measure concerns that dementia caregivers face when managing their loved 
one’s medications.  There are some obvious limitations with the instrument in its current 
form; therefore, researchers should take the findings from this scale and use them to continue 
developing a strong and useful measure of medication-related stressors of caregivers.  The 
instrument was initially developed from a small number of caregivers (n=18) who were 
either female (n=15) or White (n=13).  The instrument was then used for the first and only 
time in this research study which again lacked diversity with the majority of the caregivers 
being White middle-class.  However, based on the findings from this study, continued 
revisions of the items related to administering and obtaining medications should be made to 
strengthen them based on future research in more diverse caregiver populations.  The 
“medication effects” domain of the SCMC scale was associated with caregiver emotional 
health.  So, these relationships should be further explored.  The “medication administration” 
domain needs continued work on item development to ensure that we are capturing the 
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appropriate stressors in the part of the medication management process.  Further pilot testing 
in more diverse caregiver populations would help researchers understand if there are issues 
or concerns that were missed in the initial development of the items.  It will also be important 
to capture the qualitative findings provided from this study and incorporate them into the 
scale items.  Two issues raised by caregivers in their comments on the questionnaire were:  
(1) mail order pharmacy delays and (2) difficulties associated with prescription bottles (e.g., 
problems with bottle caps and small print).  The development of this scale is the first step for 
researchers in creating a valid and reliable instrument to measure medication-related stressors 
in dementia caregivers.   
 
 111
7.4. Opportunities for Pharmacists, Pharmacy Practice and Drug Information 
 
The research also identified an opportunity for the practice of pharmacy and the 
provision of drug information.  First, there were associations between the stress of dealing 
with medication effects and effectiveness and caregiver depression.  Targeted education for 
pharmacists and pharmacy-based interventions could be developed.  Second, caregiver 
perceptions of pharmacists and pharmacy services were distributed over all response 
categories indicating that there was a varying degree of satisfaction.  These findings create an 
opportunity for pharmacists to assist dementia caregivers by providing support and education 
and by creating an environment that is more conducive to effective communication.  
Pharmacists are likely to work with caregivers of demented patients in almost every 
pharmacy practice setting.  Therefore, it is important for pharmacists to understand the 
current treatments for memory problems, the research being done in this therapeutic area, and 
the issues faced by the patient and caregiver.  So, before developing specific pharmacy or 
pharmacist-based interventions for dementia caregivers, it will be necessary to understand 
pharmacist knowledge of dementia, its treatment and the caregiving process.  There is 
currently no published literature with this information.  A survey of pharmacists should be 
done that examines their current knowledge about: (1) pathophysiology and epidemiology of 
dementia, including the types, stages and risk factors, (2) impact of dementia on the patient 
and caregiver, (3) available treatments (prescription and over-the-counter) for memory loss, 
(4) common adverse reactions with medication treatments, and (5) the resources available to 
dementia caregivers.  This research will allow us to understand the current gaps in 
pharmacist knowledge and identify areas of continuing education that is needed in order for 
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pharmacists to be a resource to dementia caregivers.  This research could be done in 
conjunction with local, state or national pharmacist organizations that have contact 
information and access to practicing pharmacists.  Follow-up continuing education programs 
could be coordinated through these same organizations.  
Based on the findings from this current research study regarding the association 
between medication effects concerns and caregiver depression, there is a particular need for 
pharmacists and other healthcare professionals to provide information to caregivers about 
monitoring the effectiveness and side effects of medications.  This is further supported by the 
perception of pharmacists in this study, where only about 50% of the caregivers agreed that 
their pharmacist warned them about potential problems their loved one might have with their 
medication, told them what the medications are used for or gave them advice about how to 
better manage the medications.  Pharmacists can help caregivers by monitoring the patient’s 
medication profile for potential drug-drug interactions, contraindications and adverse events.  
By providing information to caregivers proactively, they will assist the caregiver in 
monitoring their loved one’s medications which should lead to a decrease in caregiver burden 
with medication management.   
This caregiver education could be done in retail pharmacy settings by using the drug 
information leaflets currently generated with each prescription.  Pharmacists could identify 
caregivers within their pharmacy setting and set a flag in their pharmacy computer system.  
When caregivers come to pick-up refills or new prescription fills, the pharmacist should 
proactively approach the caregiver to determine if they are having any medication problems 
or have had any questions since their last visit.  Longer-term solutions to educating and 
supporting dementia caregivers could be to (1) develop specific medication-related resources 
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for medications used by persons with memory problems and (2) provide local resources for 
the caregivers which might include either a flyer with local contacts or flyers/brochures 
supplied to the pharmacy by local agencies.  
While many retail pharmacies have been focusing on a pharmacy structural design 
where there is an area for patient consultation and promoting clinical pharmacy services, 
there remains opportunity for improvement in this area.  Only about 34% of the caregivers in 
this study believed that that there was a place in the pharmacy where they could talk with 
their pharmacist in private.  Pharmacists should continue working to promote an environment 
where patients feel comfortable talking with them about medication-related issues. Another 
opportunity within the retail setting is to increase the amount of time a pharmacist is 
available to provide clinical services and to continue to have pharmacy technicians 
performing the technical functions.  This is important for many patient populations but 
especially for caregivers who are dealing with their own medications and the medications of 
their loved ones.   
Finally, pharmacists must demonstrate empathy toward the dementia caregiver by 
understanding the challenges that they face and suggesting resources for them when 
appropriate.  From the information provided by caregivers in this study about pharmacist 
perceptions, only half of the caregivers believed that their pharmacist cared about their own 
health and well-being.  Pharmacists must understand that assistance extends beyond drug 
treatment for the person with dementia and drug information for the caregiver.  Pharmacists 
can provide caregivers with strategies for managing the medication process but they should 
always be reminding the caregiver to take care of themselves and to not forget their own 
physical and emotional well-being. 
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Managing the health outcomes of anyone, including dementia caregivers, requires a 
multidisciplinary approach to optimize care.  There are many health professionals (e.g., 
physician, nurse, social worker) who work with caregivers.  However, since this research 
focused on medication-related stressors and needs of dementia caregivers related to 
medication management, is important to consider pharmacy-based solutions.  Pharmacists 
can take an active role within their pharmacy practice as outlined above by identifying these 
caregivers and providing information and support to them.  Pharmacists are in a unique 
position and possess the necessary skills to improve the medication process for dementia 
caregivers.  By closing the gaps in pharmacist knowledge about dementia and caregiving 
through continuing education support, pharmacists can be an instrumental support for the 
caregiver. 
 115
7.5. Limitations and Future Studies 
 
Limitations:  This research has several notable limitations.  One of the major 
limitations of this research study is that it was cross-sectional in design and, thus, only 
captures the medication management process for these caregivers at one point in time.  
Without information on temporal relationships between medication-related stressors and 
other factors (e.g., caregiver and care-recipient contextual, caregiver resources), we have 
limited information in understanding how changes in either the stressors or other factors over 
time impact the emotional health of caregivers.  In addition to the caregiving process being 
complex, depressive disorders have a natural history and change (either progressing or 
regressing) over time.  So, there is the possibility that the responses of the caregivers were 
biased by their current caregiving situation. Also, the cross-sectional design makes it difficult 
to determine whether the modeled variables (e.g., stressors, contextual factors, resources) 
influence the emotional health of caregivers or if the emotional health status of the caregiver 
influences those other variables.  Longitudinal studies are needed to perform more detailed 
analysis of cause and effect relationships and should be considered for future research.   
Although questionnaires that are self-administered are a cost-efficient means of 
collecting data, self-report bias is also a concern when using survey data.  Another limitation 
is that the sample size is not sufficient for path analysis.  An adequate sample size is required 
to test the significance of linear relationships.  Kline (1998) recommends that there be 10 to 
20 times as many subjects as there are estimated parameters. In the regression models 
predicting emotional health outcomes there were only about 7 times as many subjects as 
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modeled parameters which would be insufficient for significance testing of the model effects 
according to Kline’s rule of thumb. 
This research, as many others involving the recruitment of caregivers, focused on 
partnering with community organizations and clinics where caregivers come for support or 
information about caring for their loved one.  There is the possibility of selection bias as the 
caregivers who participated in the study may have different characteristics than those 
caregivers who were not identified through the study selection methods.  The availability of 
community support, either by structured support groups or multidisciplinary clinical teams, 
may have confounded the findings.  The challenge in caregiver research continues to be 
identifying and reaching out to those caregivers who have not yet established themselves 
within a supportive setting within the community.  I did contact and attend caregiver support 
groups across the state of North Carolina to include both rural and urban communities.  This 
did help balance the sociodemographics of the overall caregiver sample but it did not 
completely address the issue of recruiting non-White participants.  Attempts were made to 
contact African-American churches and communities.  This strategy, however, is one that 
takes time and relationship-building.  Therefore, this research is limited in that it was done 
primarily in a White middle class population of caregivers.  Future research should continue 
to address strategies to reach the non-White caregivers as they remain under-represented in 
this type of research.  
 The 74% response rate was relatively higher than other postal research (Billinghurst, 
1993; Salisbury, 1997) and resulted in an acceptable sample size.  The multi-faceted strategy 
of reaching out to caregiver support groups, medical clinics and online support groups was 
successful with the resources that were available within the scope of this dissertation.  
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However, a research study conducted over a longer period of time with more resources may 
have yielded an even greater amount of participation.  Connecting with community-based 
organizations and medical facilities requires time to establish relationships and rapport.  I 
was able to do that within those organizations and clinics where I was involved; however, it 
is possible that a research study with more human resources could have reached out to more 
people within the same amount of time which would have increased the number of caregivers 
who were contacted.   
 This study also did not collect enough detailed information about the extent and 
quality of social support available to these dementia caregivers.  We measured social support 
with only one instrument that assessed the caregiver’s subjective social support.  There was 
no assessment of direct support available to caregivers for medication-related 
responsibilities.  Caregivers need to be surveyed in future research about the types of people 
available to them to help with medications (e.g., friends, family, paid help, home health), the 
availability of that help (e.g., daily, occasionally, rarely) and what types of medication-
related responsibilities the substitutes can handle.  Since there is limited research in this area, 
this information would best be obtained through caregiver interviews or focus groups where 
caregivers could respond and elaborate on these issues. 
 The limitations of the study questionnaire were outlined in Section 7.3 of this chapter.  
However, it is important to emphasize the fact that more work should be done to refine the 
scale that was created to assess medication-related stressors in dementia caregivers.  The 
scale was developed using two focus groups in one community.  A more focused effort on 
collecting qualitative information through focus groups and/or surveys among caregivers 
from different communities and with different socioeconomic backgrounds should be done.  
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This will allow for further refinement and testing of this instrument in this population and 
allow us to confirm and expand on the results found within this study.   
We were also not able to completely understand the impact of medication-related 
problems on those caregivers who are employed.  There was instability in some of the 
variables when modeling due to the low number of respondents within a specific category 
(e.g., non-Whites, not living with the care-recipient).  Therefore, this analysis was not able to 
be completed to test the original hypothesis and aims of this research.  From conversations in 
support group meetings with caregivers and based on hand-written comments on the study 
questionnaire in this research, there are concerns from caregivers about the impact that 
medication management has on their employment and job performance.  However, we were 
unable to draw any conclusions from this research study. 
  
Future Research:  There are several specific suggestions for future research.  First, 
we should use the findings from the development of the Survey of Caregiver Medication 
Concerns scale and continue to rigorously examine and refine the instrument so that it can be 
used in future research of dementia caregivers.  The refined instrument should be tested in a 
larger and more diverse population.  This will allow us to describe in greater detail the 
impact of medication management on the emotional health of caregivers and will offer 
greater generalizability.   
Second, we should further examine the role of a pharmacist in assisting caregivers of 
persons with memory problems.  This study offers feedback from caregivers about their 
perceptions of pharmacists and pharmacy services.  Surveying pharmacists about their 
knowledge of dementia and the role of caregivers would be an important next step.  Using 
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gaps in knowledge that are identified from this type of survey along with the perceptions of 
caregivers outlined in this current study, it would be possible to make recommendations for 
pharmacy-based interventions that might include pharmacist education or pharmacy-based 
services for caregivers.  Pharmacists are in a unique position to provide information and 
support to these caregivers and the findings from this study demonstrate that, as a profession, 
they are not currently meeting this need.   
The next step should be an intervention study with a longitudinal design so that 
caregivers can be surveyed at several points in time.  The intervention could be based on 
information taken from this current research study.  We learned that the concern of 
medication effectiveness and side effects is associated with poorer emotional health in these 
caregivers.  So, an educational intervention should be considered that is targeted at providing 
drug information on (1) the use of the care-recipients medications, (2) potential 
contraindications, (3) potential drug-drug interactions, and (4) adverse events that might be 
expected.  
Finally, more research should be performed to understand the differences between 
caregivers who use mail order pharmacies and those who use a local chain or independent 
pharmacy.  One would expect that the relationship between the caregiver and their 
pharmacist and the level of pharmacy support would be different based on where they receive 
their loved one’s prescription medications.  Other research that was outside the scope of this 
dissertation research is to perform further bivariate and multivariable analyses in order to 
understand the impact of the individual pharmacy satisfaction items on caregiver emotional 
health.  This would also help to guide a framework for pharmacy-based interventions. 
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CHAPTER EIGHT 
CONCLUSION 
 
This research was a step in beginning to understand the impact that managing 
medications has on dementia caregivers.  Our findings suggest that medication-related 
stressors are associated with poorer emotional health outcomes in caregivers.  Our 
descriptive analysis of caregiver’s attitudes about pharmacists and pharmacy services also 
suggests that there are things that can be done to assist caregivers to improve the relationship 
and communication with their pharmacist.  Help with medication-related stress can, however, 
is accomplished in many settings and by a host of informed professionals in addition to 
pharmacists including physicians, nurses, social workers, and support group facilitators.  
Hopefully, findings from this dissertation research will be one more step in the process of 
identifying areas of concern for dementia caregivers and designing interventions that will 
ultimately improve their emotional health outcomes. 
 
 
Appendix 1 
 
Focus Group Script 
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Focus Group Question Guide 
 
Impact of Medication Management on Caregivers of Demented Patients 
 
 
 
Introduction:  Tell us your first name and how long you have been a primary caregiver. 
 
 
When you think about managing your loved one’s medications, what comes to mind? 
 
 
What are the most stressful parts of managing your loved one’s medications? 
 
 
How has managing your loved one’s medications impacted your relationship with him/her? 
 
 
How has managing your loved one’s medications impacted other activities (work, social 
events, family time, etc)? 
 
 
Where do you typically receive information about medications? 
 
 
Where do you currently receive your loved one’s medications (e.g. chain pharmacy, 
community pharmacy, mail order)? 
 
 
How does your pharmacist help with managing the medications? 
 
 
How could your pharmacist help with managing the medications? 
 
 
Ending:  We want to try to better understand the role of caregivers in medication 
management.  What advice would you give us? 
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Appendix 2 
 
Study Questionnaire 
Caregivers of Persons with Memory Problems:  The Medication Study 
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Appendix 3 
 
Follow-Up Procedure Letters 
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INITIAL COVER LETTER 
 
 
 
 
Division of Pharmaceuctical Outcomes and Policy 
 
 
 
 
 
Dear Caregiver: 
 
I wanted to take the opportunity to thank your for your interest in completing the questionnaire, 
Dementia Caregiver Medication Study, that you received.  We do believe that your responses will 
help us better understand the overall stress and burden associated with medication management for 
dementia patients.  It is our hope that the study will identify potential opportunities for pharmacy 
interventions for AD patients and their caregivers. 
 
I am a fourth-year doctoral student in the School of Pharmacy at the University of North Carolina.  I 
have been a practicing pharmacist for over 13 years and I am moving into a research career upon 
completion of my PhD later this year.  My work experience and research interests are in the aging 
population and in mental health.   I have been involved for several years now in research of 
caregivers and persons with memory problems.  During that time, I have met many wonderful people 
who care for a loved one on a daily basis and the work has been extremely fascinating and 
rewarding.  I am convinced that we will never understand the real challenges of caregivers unless we 
reach out to you and allow you to share your experiences.  I know how busy you are as caregivers 
but would appreciate you taking the time to answer the questions on the enclosed study 
questionnaire. 
 
Thanks for your contribution to this dissertation research effort.  Should you have any questions, you 
can reach me by telephone at 919-674-2535 or by email at jbyrd@unc.edu.  
 
 
Kind regards, 
 
 
 
John Byrd, RPh MBA 
Study Coordinator 
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FIRST FOLLOW-UP—THANK YOU LETTER 
 
 
Division of Pharmaceuctical Outcomes and Policy 
 
 
 
 
 
Dear Caregiver: 
 
 
I appreciate your interest in completing the questionnaire, Dementia Caregiver Medication Study, that 
you received last week.  We do believe that your responses will help us better understand the overall 
stress and burden associated with medication management for dementia patients.  It is our hope that 
the study will identify potential opportunities for pharmacy interventions for AD patients and their 
caregivers. 
 
Thanks for your contribution to this research effort.  Should you have any questions, you can reach 
me by telephone at 919-674-2535 or by email at jbyrd@unc.edu. 
 
 
Kind regards, 
 
 
 
John Byrd, RPh MBA 
Study Coordinator 
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SUBSEQUENT FOLLOW-UP LETTER 
 
 
Division of Pharmaceutical Outcomes and Policy 
 
 
 
 
 
 
 
Dear Caregiver: 
 
I wanted to take the opportunity to thank your again for your interest in completing the questionnaire, 
Dementia Caregiver Medication Study.  We have not received a completed questionnaire from you 
and are sending you another copy along with a self-addressed stamped envelope.  If you have 
already mailed it, disregard this mailing and thank you for your response. 
 
We do believe that your responses will help us better understand the overall stress and burden 
associated with medication management for dementia patients.  It is our hope that the study will 
identify potential opportunities for pharmacy interventions for persons with memory problems and 
their caregivers. 
 
Thanks for your contribution to this research effort.  Should you have any questions, you can reach 
me by telephone at 919-674-2535 or by email at jbyrd@unc.edu. 
 
 
Kind regards, 
 
 
 
John Byrd, RPh MBA 
Study Coordinator 
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Appendix 4 
 
Caregiver Handwritten Comments 
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I have responsibility for packing my mothers pill packer.  I don’t live with or too near her (30 
minutes away), so, my sister occasionally has to fill in--packing them if I get in a bind and 
cant get home, or if we are waiting on a refill with the pharmacy.  Although we have done 
this around two years now, my sister has just told me my mother doesn't take it as regularly 
as I had thought.  We are not considering getting a home health person to come daily to give 
her morning medications and help with taking care of laundry, light household chores.  So, 
we are at a transition point.                 
                                                                                                                                                                              
It is hard to afford medication for my spouse and myself.  I spend most of my time worrying 
about affording medication.  I have very little help taking care of my spouse.  It is mostly my 
responsibility.  Her doctors suggested she quit taking her Alzheimer’s medications.  She has 
truly improved and I had to convince them not to.  I would love get her on the newly tested 
medication but I'm not sure how to do this.  I worry about getting my pain medication so i 
can continue to care for my wife properly.                                                                                                           
 
I would love to figure out a way to get prescriptions scheduled together so that I don’t need 
to go to the pharmacy every week.  I cannot figure out how to accomplish this.                                                 
You should ask about anger, annoyance, irritability, how time is divided into tiny segments 
that make sustained effort difficult.  Also, I have some household help and some caregiver 
help.  Otherwise, I would be in constant back pain and probably on the psych ward.              
                                                                                                                                                                              
It would be helpful if the pharmacy was able to give all prescriptions at once instead of at 
different 30 day periods according to date prescribed.        
                                                                                                                                                                              
Because my husband took no medications for the first 47 years of our marriage, it has been 
difficult for me to adjust to any schedule past the first thing in the morning.   
 
Especially it has been difficult to give meds near dinner time if we are out for unplanned 
dinner.  I forget, but only rarely.  Still, I feel bad about it.  We both have great love for God 
and experience the miracle of his constant care and provision and smiles.  We have close 
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family and friends and neighbors who also love and care for us.  The Support Group led by 
Kate Barrett has been a tremendous blessing to me.                           
                                                                                                                                                                              
I take care of 2 seniors in my home.  I find it important to stay in touch with their doctor--
read and understand all medicines.  I give them their meds at the same time every day.  I use 
the same pharmacy all the time.                     
                                                                                                                                                                             
I wish that my parents had planned earlier to move to an assisted living home.  I understand 
that they want to be "at home," but at this stage, they are unable to do the things they could 
even last year--housekeeping and cooking and bathing.  Falls are beginning and that concerns 
me greatly for I am not with them 24 hours.  My parents do not wish to talk about end-of-life 
issues, and that concerns me, as well as the house and its maintenance.  So, we take one day 
at a time and continue to count our blessings.                                                                                                     
 
It is very helpful and mind-easing to be able to visit a clinic like the ACC.  Although my 
mom has a regular doctor, he doesn't seem to be in touch with the elderly person's problems.  
Having us sit in one room with the physician, pharmacist, OT cuts down on some confusion 
and anxiety that may have occurred if we had to go office to office.  It was a pleasant 
experience with kind and caring people.                                                                                                               
                                                                                                                                                                              
I have had no problems with medications.  Doctors have been very willing to change any that 
show adverse problems.  It is difficult to have to care for a six foot man who displays many 
childlike behaviors.  You change your way of thinking and dealing with situations at home 
and in public.  It is hard to deal with an adult and child which can change in a second.                                     
                                                                                                                                                                              
We are learning to be happy.  I still have trouble on 'pill day.'  I fill 2 weeks of pills for 
husband and me.  It s a chore and I need quiet time to do it.  I do all the shopping, cooking, 
finances, laundry and doctor visits for him and me.  He does not drive.  We have 2 or our 5 
children here in Greensboro and they are very helpful in checking on us and doing for us.  
One daughter is in Texas and calls us for her sibs weekly.  2 daughters are 50 minutes drive 
from us and come as often as they can.  We had trouble for years paying for meds.  Then Gov 
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Easley paid 90% on our meds for a year.  Now my husband has qualified for VA meds and I 
am working on a Medicare plan.  My biggest job is trying to stay healthy and cheerful for our 
last years together.                                                                                                                                                
                                                                                                                                                                              
The business of caring for my husband, giving attention to my mother who is in assisted 
living, managing our finances, selling our home, finding a place to live, working part time, 
and trying to maintain a relationship with seven in-town grandchildren, makes managing al's 
medications a nightmare.  I am overwhelmed with responsibility, but I am also blessed with 
wonderful support from family and friends and a deep faing in loving and sovereign God.               
                                                                                                                                                                              
My answers about obtaining medications will change dramatically when Lucent drops his 
drug plan.                                                                                                                                                              
                                                                                                                                                                              
The occasional feeling of being overwhelmed seems to come from a sense of having total 
responsibility for not only the care of my husband but all other aspects.  The low feelings 
pass fairly quickly and have not needed outside intervention.  When he has a bad day with his 
vertigo, I tend to be more anxious and depressed.  Outside activities help.                                                         
                                                                                                                                                                             
The role of caregiving is the most difficult thing I have ever faced in my life.  Being a 
caregiver for your spouse involves so many different problems.  The feeling of loss is so 
great and is hard to deal with.  It would be good to have someone to talk to about it.                                         
                                                                                                                                                                              
At times it is hard for my wife to take her medicines.     
                                                                                                                                                                              
Because giving the right medicine in the right dose at the right time is so important, I have 
always used a pill box.  When my dad could no longer remember what day of the week it 
was, I put a red dot using nail polish on the lid for Sunday telling him this is God's day and 
the red dot represented the blood of Jesus shed for us.  That kept him straight for a long time.  
Thank you for caring enough to do this study.  
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Hendersonville has an outstanding adult day care and I take my wife there 5 days a week.  I 
have to attend to my wife nights and weekends.  Without this facility, both my wife and 
myself would be in institutions because I can not care for her 24/7.  My wife is in the late 
stages of Alzheimer’s.                                                                                                                                           
                                                                                                                                                                              
Concerns:  1. Forgetting to give 2. Forgetting to order.  3. Not know all various names of 
same med.  4. Difficulty in keeping up and planning for trips, emergencies, etc.  Medications 
are easiest of cargiving but still a constant sole responsibility of caregiving.  It is impossible 
to imagine without organizer, money and insurance.  Outside help is often more trouble than 
help.  There is no free lunch.                                                                                                                                
                                                                                                                                                                             
The hardest thing about caregivng is being patient, and not getting frustrated.  No one 
understands.                                                                                                                                                          
                                                                                                                                                                              
The most difficult time was when I recognized my husband's severe memory loss and he 
continued to deniy it and would not seek help.  After 3 years, he came to me for help and I 
took him to a neurologist whoe ordered an MRI of his brain and determined it was shrinking 
rapidly.  He also did a 4 hour neuropsychological test to let us know where he was mentally 
at this point.  Very helpful information and began him on 5mg of Aricept and later increased 
to 10mg.  Switched to a geriatrician who have been invaluable.  My husband has not known 
what medicines he has taken for years.  I put them in a cup for him and he takes them.  He is 
very trusting which is good.           
                                                                                                                                                                              
My father does not like to do very much.  He spends a lot of time in bed and resists many 
efforts to encourage him to spend more time up and around.  He avoids bathing or showering.  
He also seldom washes his hands.  Every day, I wake him up to take his pills, do exercises 
and take a walk.  He is not much of a bother but his extreme lack of initiative can not be 
healthy for him.          
                                                                                                                                                                              
Support groups are great!  Caregiver conferences are great.                                                                                
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I became a caregiver for my mother-n-law and she moved in with us in December 2005 as 
we lived in North Carolina and she was in Ohio.  We felt her health was going downhill and 
we needed to get physicians here to help her.  She had pneumonia reoccurring.  When she 
didn't eat, her memory got very bad.               
                                                                                                                                                                              
I have no problem preparing my husband's medications or going to the pharmacy to pick 
them up.  As for my feelings about my feelings as a caregiver, I feel that I am where God 
wants me to be.  I feel abandoned and alone.  I am with Fred 24/7 but I can do it.  I miss 
volunteering and working.  I enjoy working and being with people.  I go to a support group 
meeting once a month if there is someone to relieve me.  I miss being able to go to the 
hairdresser or to shop.                                      
                                                                                                                                                                              
I am providing the best care that I can to sick husband.  I am glad I have strength to care for 
him.  He is not a complainer.                                                                                                                                
At this time, my Dad has Medicaid and is on CAP.  I have help Monday through Friday.  
CAP aide stays during this time.                                                                                                                           
                                                                                                                                                                             
I listen to their concerns and give them the best answer possible.  Assure they get the correct 
medicine at the right time.   
                                                                                                                                                                              
I wish that you could get a deduction on tax for expenses for caregiving.      
                                                                                                                                                                             
Always give your loved one the medicine he or she needs.  I have looked after my husband 
for many years because he has Alzheimer’s.  My mother also has Alzheimer’s.  I also have to 
look after my son who is a bad diabetic and has had open heart surgery because of bacterial 
endocarditis caused by infected teeth.       
                                                                                                                                                                              
Try to be patient.  Put meds in their hands.  Try to make them like a bath.  Try to get them 
outside some.  Try to fix meal that is good for them.  Pray all the time for yourself as well as 
your mate.  Try not to feel guilty.                                                                                                                         
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Finding the right medication for someone with depression/anxiety can be hard sometimes.  
She seems to get immune to them after a certain period of time.  I have to fill pill containers 
for myself plus four other people.      
                                                                                                                                                                              
We do use a pill divider on a weekly basis.  It is very helpful.  It would be a lot more helpful 
if all his medications could be renewed on the same date.  Because they are renewable at 
different times, it seems I am always either ordering prescriptions or going to the drug store 
to pick them up.  As a veteran, we are very fortunate to have Tricare coverage with a very 
low copayment.  I cannot imagine what our financial situation would be without it.                                  
                                                                                                                                                                              
I was dismayed to learn that Detrol LA can counteract the results of Aricept.  My husband 
tool Detrol LA for 5 months before I found that "high risk" on CareMark's website.  The 
prescribing doctor and his neurologist were both aware of the Aricept for 5 or 6 years before 
the Detrol was prescribed and neither warned me.  The pharmacist at CareMark said his info 
did not show that risk but their website's medicine interaction feature warned of "high risk."  
My husband's MMSE had stayed at 29 for one year, then dropped to 26 in 6 months; the next 
6 months it dropped to 24; during the 6 month period he took Detrol LA, it dropped to 18.  
Somebody need to do a regulated study about this.  
                                                                                                                                                                              
I sometimes feel that she is not really sick and does not want to do for herself.  I just guess I 
dont want her to be sick.  She likes to talk to people she doesn't know and just stays and 
stares them up and down and then says "you have a good day."     
                                                                                                                                                                             
Usually obtain medications through a mail order service through patient's retirement plan.  
Stress in caregiver's life relates to a lot of other stuff in addition to dealing with Alzheimer's 
patient.                                                                                                                                                                  
                                                                                                                                                                              
My husband has just started not wanting to take his medication.  We take it in the morning 
after breakfast and we just play a little game to coach him to take it.  Usually after coaxing, 
he would take it.  I have found that love and kindness helps more than anything.  Lots of 
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prayer and patience.  I hope the information I filled out will be of help to you.  No one knows 
what it is like until you are in the role of caregiver.                                                                                             
                                                                                                                                                                              
The cost of nursing care is phenomenal.  One needs to be a millionaire to afford the monthly 
costs.                                                                                                                                                                    
 
Caregiving is: necessary, demanding, satisfying, overwhelming, physically draining, at times 
invigorating because it requires creativity and problem-solving, a source of worry.  
Caregiving is about loving.                                                                                                                                   
                                                                                                                                                                              
I guess one of the hardest things to do was to take control of my mother's medications.  It 
was a challenge but I have learned as a caregiver you have to become tough.  You have to 
take a lot of verbal abuse.  You have to always remember how the person was before they got 
sick.  You have to remind yourself daily that this is not my mother; this is the Alzheimer's 
disease that has robbed her of all the things she used to be.  It is hard to watch a loved one 
lose their independence, their memory, their dignity and their sense of well-being.  Thank 
you for choosing this research field about memory loss.  Hopefully one day there will be a 
cure for this disease.  As a caregiver, I face a lot of challenges.  It is hard to work, care for a 
loved one and still manage things with your own family.  The juggling of things is not always 
easy.  Sometimes this stress is almost overwhelming and hard to bear.  Prayer and my faith in 
God is what keep me going.  May God bless you!                       
                                                                                                                                                                              
It would be nice to have all the doctors get together to see if any or all of the medications are 
working together, against each other or are okay.              
                                                                                                                                                                              
Family members do not offer help of call to ask how I am doing.  I don’t want to lose friends 
by complaining about my situation.  If they have never been a caregiver, they have no idea 
what it is like.  My husband and I saved for our retirement and have long term care insurance.  
However, there is no financial aid for middle income people.   I have to spend money I need 
for my future and that we had hoped to travel with to pay for the part of the medications with 
big deductibles.  I am on10 prescriptions and have the same situation with Medicare.  I 
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already feel like I am drowning.  Everyone seems to think that seniors are wealthy but we are 
living off savings that won’t last forever.   
                                                                                                                                                                              
Medications at this point are not a problem for me but managing all of the issues is very hard 
for me.  The one major problem is communication.  This makes everything a very serious 
problem.  As well as having to do 99% of all things, I can not understand what my wife is 
saying or what she may want.  I just try to work with her and do the best I can.                                                 
                                                                                                                                                                              
I doubt that things would be as organized as they are if I was not retired.  I do have a good 
support system with other siblings and my husband.  Even so, being a caregiver is mentally 
straining and because I must use my own money to help for my mother's care, I wonder what 
will be left for me.  I prepare my mother's medications including insulin needles which help 
greatly.  My siblings and I pay others to help with my mother's care and that, too, relieves me 
more.  My mother is mentally alert but wheel-chair bound.        
                                                                                                                                                                              
The caregiving responsibility is on my shoulders all day, every day--it never ends or goes 
away.  One of the most difficult things is dealing with my father's memory deficits and his 
total lack of awareness or insight that anything is wrong.  I have never been a patient person.  
You have to have great patience and empathy.  It becomes very frustrating.  He is very slow.  
I miss the father I used to know and being able to have a meaningful conversation with him.  
I have to constantly remind myself he is not doing this intentionally--his brain is no longer 
working the way it used to.  I do take it personally when he yells or tells me I am lying.  
Thank you for wanting to know.  I hope your career will help caregivers. 
                                                                                                                                                                              
I dealt with the emotional/mental/psychological impact on my life for many years.  The 
wake-up call for me was the physical impact.  When my blood pressure went sky high and I 
had heart palpitations, joint pain and depression, I went to my Doctor.  I was a MESS!  
Thankfully, he steered me to therapy, meds for my joint pain and now, I know, I must take 
care of myself so that I can take care of my husband.  I am in therapy, I am taking meds for 
my RA and I am back at the Y, back with friends playing bridge and putting myself first, 
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which is very difficult for mothers and teachers.  I teach Kindergarten and care for my 
husband.  I am finally letting go.  
                                                                                                                                                                              
Thank you, John, for coming to our meeting in Yadkinville.  It was good to meet you.  Hope 
this helps in your study.                                                                                                                                       
                                                                                                                                                                              
I am fortunate that my husband enjoys generally good physical health.  Therefore, he takes a 
limited number of meds.  All his meds but one are taken at night.  I have a separate container 
for morning and evening meds.     
                                                                                                                                                                              
My husband's MRIs have come back normal but one-on-one testing has a diagnosis of 
beginnings of dementia.  His memory falters slightly but his logic/reasoning skills have 
slipped considerably more.  We moved to North Carolina as younger retirees.  My health 
insurance is free for both of us with meds being $5/$10/$20, office visits $5 through my NJ 
State Employee pension.  My biggest problem is dealing with all this emotionally.  He 
constantly misinterprets, thus causing emotional conflict.       
                                                                                                                                                                              
One of the most frustrating things about medications is that they all seem to need refilling at 
different times which calls for many trips because you can only get a 30 day supply.                                        
                                                                                                                                                                             
My mother was able to live alone with some assistance until October 2005 at which point I 
took family medical leave and went to live with her.  I moved her to my home in December 
2005.  When Mom began getting up during the night, I found I couldn't manage during the 
day without sleep.  Mom doesn't take much medication.  I have to admit that I can not care 
for her myself.                                                                                                                                                       
                                                                                                                                                                              
My friends and my religious community are better to me than my family.  Health care 
beauracracy in America is difficult to navigate.  
                                                                                                                                                                              
I moved back into my Father's home in order to care for him.  Eventually, I had to stop 
working too.  So, when you ask how many times did I miss work or was late for work or 
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could not participate in social activities, I dont know how to give a meaningful answer.  My 
entire life was disrupted.  A big problem occurred with Medco when they would require 
additional paperwork from the MD for both of Dad's medications.  The MD felt she should 
not have her judgement questioned and procrastinated in filling out the forms.  As a result, 
shipment of medications was delayed.  This was very stressful.  At Rite Aid, the pharmacist 
would make sure I signed a form saying I had refused advice from them.  They never offered 
to give me advice; they just made sure their backs were covered.  I think there are so many 
other issues in regards to medications:  what do you do when they can’t swallow, drug 
interactions, and diarrhea.          
                                                                          
Meds management isn't all that hard if you are organized about it.                
                                                                                                                                                                              
We manage his and my medications together since Oct 2005.  We don’t have funds for all 
necessities except with great care.  I handle all finances.  He is given money which helps him 
feel he is in control.  It is a great job to keep up with ordering refills and staying ahead of my 
21 pills a day as well as his.  He fell last night.  
 
Sometimes for seemingly no reason he changes moods and has a flare of anger.  It hurts my 
feelings.  Normally he is very nice.  It is exhausting.  I can't begin to tell all here.   
                                                                                                                                                                              
My sister has Downs Syndrome with dementia.  I find it easy to organize meds but do find it 
hard to remember all the names and generics.  Complicated keeping track of side effects of 
meds, I think.                           
                                                                                                                                                                              
One of the hardest things to realize was that my Mom could no longer manager her meds.  
Now the issue is to get her to take them.  A major issue is if she is on an antibiotic and has to 
take it three times a day.  Morning and night is doable since I live next door; however, the 
lunch dose means that I have to leave work to ensure that she gets her meds.                                                     
I also have a 14-year old son.  While he can be very helpful, the situation is very difficult for 
him to deal with day in and day out.  We have only had one break in the last 5 years and that 
was for 4 days.                    
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Seems that the caregiver has to be on "red alert" at all times.  The memory deficient patient 
cannot be expected to keep track of medications and even if you pared down only one doctor, 
they are overloaded and busy.  The caregivers carry most of the burden in making sure that 
the meds are ordered, refilled, given and re-ordered.  We order 90-day supply but with 15 
prescriptions I have had to use an Excel spreadsheet to keep track of the meds.  Giving the 
meds with the help of a pill organizer is a snap.  Keeping the supply coming is a challenge.                             
                                                                                                                                                                             
The most stressful part of medications for me has been regulating meds that treat agitation 
and sleep disorders.  Our GP wasn't up on the latest and tried to just sedate the patient rather 
than treat for agitation.  So with new doctor, we had to experiement with different things 
before we found something that didn't make her unstable if she did get up during the night 
yet settle her enough to reduce night time rising to once or twice a night, rather than every 
hour or half hour.                                                                                                                                                 
 
Caregiving is a very hard job.                                                                                                                               
                                                                                                                                                                              
Always remember to do the best that you can according to your ability in all that you learn or 
by experiences and do it to the fullest.                                                                                                                 
                                                                                                                                                                              
It is very hard to care for my mother and work but I know she is better off at home.  
Unfortunately, there isn't enough help or money to keep her at home indefinitely.                                            
                                                                                                                                                                              
Caregivers need respite regardless of their income.  The cost of providing aide to the 
caregiver in their home would be far less than placing the patient in a skilled nursing facility.  
Also, noted that no question addressed whether or not meds ever administered incorrectly, 
which I have done.  And I have learned to manage repeated questions by placing a dry erase 
board on wall in front of patient's chair with day of week, appointments, meds, etc. listed on 
it.  One last thing, I keep a photo album near patient with photos and notes regarding family 
and friends.                                                                                                                                                            
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My husband has been very stable in the last 2 years since his diagnosis.  Meds, so far, seem 
to be working; however, I am concerned and afraid about our future and financial matters.                    
                                                                                                                                                                              
Wife has Alzheimer’s; soon she will not be able to take meds oral without putting in food.  
Son is MD.  Always good have a doctor available 24/7.  I am depressed but dealing with it.  
Will have to place wife in nursing home in the next year, probably.                                                                   
                                                                                                                                                                              
Because the meds are limited to 3 meds some of which are administered night and morning, I 
have not experienced any problems except remembering at nighttime when I am very tired.  
If caregiving was all that I had to do, life would be much better for me.  I am trying to 
organize and prepare to sale a used book business that belongs to my husband in addition to 
working another part-time job.  The book store 5 days a week and working the part-time job.  
My home is in disarray because I have no time to clean it up.  I take my husband with me to 
the bookstore during the day.  My day starts at 3am and I get to bed about 830 or 900 at 
night.  My husband is in early stages.  I am already exhausted from everything.     
                                                                                                                                                                              
Because Mother sleeps most of the time now and refuses to communicate much of the time, 
care sometimes seems routine.  Because she has trouble swallowing or understanding what to 
do with meds, her meds are all liquid and administered or included in a shake, mixed with 
jelly or inserted by oral syringe in the mouth then encourage swallowing.  I use a checklist 
now instead of the boxes I used when she could take pills. 
                                                                                                                                                                              
Without the assistance of my husband, this would not be possible.  Between the two of us, we 
provide 24 hour care and supervision for my mother.  He is a saint!      
                                                                                                                                                                              
My wife can not speak, walk, or take care of herself in any way.  We have a "live-in" aide 
who does much of the work of caring for my wife.  My doctor told me about two years ago 
that my health was at risk if I continued to be the sole caregiver for my wife.  So, I hired the 
aide who now does most of the work.    
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My mood and stress levels are greatly dependent on my Dad.  Currently, he is somewhat 
stable, physically and emotionally.    
                                                                                                                                                                              
I have only recently stepped in as the primary caregiver.  My Dad managed the care for the 
past 5 years. He passed suddenly in December leaving me to this task.  I have no idea how he 
managed so well.  I am exhausted!                                                                                                                       
                                                                                                                                                                              
I am a full-time caregiver for my wife with AD.  I currently have 10-20 hours/week of 
assistance.  Full-time care has been required since AD was discovered in 2000.  She refuses 
to take pills many times but will most times after a period of time.  Will not take medication 
crushed or mixed or with food.  I attempt to have the doctor write the prescription with the 
smallest number of pills. 
                                                                                                                                                                              
The most difficult part of caregiving is the lack of respite time, the freedom to enjoy time to 
do the things I like to do, and the physical toll that I have paid.  My mother-in-law has lived 
with us for almost 9 years.  Although I have lost touch with many of my friends, I do not feel 
they have abandoned me.  Rather, I feel that sometimes as caregivers we abandon our friends 
because we do not have the time or energy to nurture those friendships.  That is the greatest 
feeling of sadness for me.    
                                                                                                                                                                              
My mother does a lot for herself.  I help with all detailed things like her medications.  She 
forgets things, gets lost at times.  She is depressed.  I am on antidepressants.  I keep going 
and I am the "hub" of my family.  Good luck in your research.  
                                                                                                                                                                              
It is stressful keeping up with prescription renewal.       
                                                                                                                                                                              
I have an almost ideal situation.  My mother-in-law came to live with us last August.  We 
have thoroughly enjoyed her stay with us.  She has always been in good physical health as 
she was a walker and a swimmer.  The meds are relatively easy for me to handle with a pill 
reminder.  I do set up her meds and assist her with taking them but it has posed no serious 
problems thus far.  I am blessed and I know it...Thank God!                                                                              
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Recently, she was disoriented and I found she had taken 2 days of medicine one morning.  I 
don't know if she was disoriented and forgot and took the medicines OR if she took all the 
meds and that caused the disorientation.  Now I hide the meds and give them to her to take 
morning and evening.  It is something else that I have to remember to do!                                                         
                                                                                                                                                                              
This journey is an overwhelming task and I often wonder if I am up to it.  My two greatest 
fears:  1. I will not be able to care for my husband as long as I should.  2.  I will kill myself 
trying.  He has been an incredibly wonderful husband for nearly 40 years carrying much of 
the weight.  Can I carry all of it?  We shall see...                                                                                                 
                                                                                                                                                                             
Managing medications is difficult because of ways some of it is given.  One is supposed to be 
taken alone before breakfast.  One day a week a medication has to be taken sitting or 
standing for 1/2 hour before eating.  Have pretty much given up giving first medication 
because of Mom's sleep habits and my schedule. 
                                                                                                                                                                              
With so much aid out there for pregnant, unwed girls and people who won't work, it is a 
shame that the only aid that I can get is 50 hours a year!  It is rewarding taking care of my 
mother who is 75 with Alzheimer's but the most stressful I have ever had.  My mental health 
has suffered so much along with my marriage.  There should be more ways to help 
caregivers.                                                                                                                                                             
                                                                                                                                                                              
I do use the pill box and love it.           
                                                                                                                                                                              
I try to be very calm and observant.  I take deep breaths and concentrate on what I am doing.  
Safety is my first goal.  I do not rush or hurry.                                                                                                     
                                                                                                                                                                              
Managing my mother’s medications has changed in the eight years I have been her caregiver.  
She had a number of crises in the beginning--one drug gave her hallucinations, others gave 
her severe diarrhea.  I did not know she was allergic to sulfa drugs.  Now her condition has 
been stabilized by correct medicines.  Pharmacists and doctors need to be aware that not 
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everyone coming on board as a caregiver is necessarily equipped with the skills to do it.  The 
new Medicare prescription plan with is "doughnut hole" is a terrible deception on the elderly.                         
                                                                                                                                                                             
Medicine bottle caps are difficult.  Insurance is a pain.  The print on medicine bottles is too 
small.                                                                                                                                                                     
                                                                                                                                                                              
I find giving her meds more challenging as her swallowing problems increase.  I now crush 
most of them and mix them in applesause or pudding.  I was the one who initiated switching 
to liquid forms of any of her meds when possible.  I worry with crushing them that she is not 
getting the full dose.  I also care for my father who has dementia but he is able to dress, feed 
himself, etc.  I have a teenage sone still in the home that is impacted by all of this.  I cut back 
to part-time work for about 3 years until finally I realized I needed to quit altogether in order 
caring for her.  My family was uprooted and moved to a different state so we could all live in 
one house.  Good luck with your study.  I hope it helps other caregivers!                                                           
                                                                                                                                                                              
It is very depressing to take care of my mother like she is a child.  She is quite a load at times 
but I deny myself to take care of her.  I spend most of my day around her with not much 
sleep at times.                                                                                                                                                       
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